[
  {
    "title": "A promising new therapy for ALS",
    "authors": [
      "Wood, Heather"
    ],
    "abstract": [
      ""
    ],
    "url": "https://doi.org/10.1038/s41582-021-00504-w",
    "journal": "Nature Reviews Neurology",
    "keywords": [
      "amyotrophic lateral sclerosis",
      "AMX0035",
      "CENTAUR trial"
    ],
    "caption": "Exciting news in the fight against ALS! üåü The investigational drug AMX0035 shows promise in improving survival and function for those with amyotrophic lateral sclerosis. Presented at the AAN Virtual Annual Meeting, the CENTAUR trial highlights the potential of this coformulation of sodium phenylbutyrate and taurursodiol. These compounds target endoplasmic reticulum stress and mitochondrial dysfunction, respectively, offering a synergistic neuroprotective effect. This development is a beacon of hope in neuroscience, paving the way for innovative treatments in neurodegenerative diseases. üß†üí™\n\n#ALS #Neuroscience #Innovation #Hope #Neuroprotection #ScienceNews #HealthBreakthroughs",
    "images": [
      [
        {
          "title": "File:Browser problems with Scholia profile for Amyotrophic lateral sclerosis as of 2019-11-18 at 20.47.06.png",
          "author": "<a href=\"//commons.wikimedia.org/wiki/User:Daniel_Mietchen\" title=\"User:Daniel Mietchen\">Daniel Mietchen</a>",
          "description": "Browser problems with <a class=\"external text\" href=\"https://tools.wmflabs.org/scholia/topic/Q206901\">Scholia profile for Amyotrophic lateral sclerosis</a> as of 2019-11-18",
          "credit": "<span class=\"int-own-work\" lang=\"en\">Own work</span>",
          "license": "cc0",
          "url": "https://commons.wikimedia.org/wiki/File:Browser_problems_with_Scholia_profile_for_Amyotrophic_lateral_sclerosis_as_of_2019-11-18_at_20.47.06.png"
        },
        {
          "title": "File:Scholia topic profile for amyotrophic lateral sclerosis as of 2019-12-06.png",
          "author": "<a href=\"//commons.wikimedia.org/wiki/User:Daniel_Mietchen\" title=\"User:Daniel Mietchen\">Daniel Mietchen</a>",
          "description": "<a href=\"//commons.wikimedia.org/w/index.php?title=Toolforge/scholia/topic/Q206901&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Toolforge/scholia/topic/Q206901 (page does not exist)\">Scholia topic profile for amyotrophic lateral sclerosis</a> as of 2019-12-06",
          "credit": "<span class=\"int-own-work\" lang=\"en\">Own work</span>",
          "license": "cc-by-sa-4.0",
          "url": "https://commons.wikimedia.org/wiki/File:Scholia_topic_profile_for_amyotrophic_lateral_sclerosis_as_of_2019-12-06.png"
        },
        {
          "title": "File:ALS Affected neurons and muscles.png",
          "author": "<a href=\"//commons.wikimedia.org/wiki/User:PaulWicks\" title=\"User:PaulWicks\">PaulWicks</a>",
          "description": "Diagram of a human highlighting the areas affected by amyotrophic lateral sclerosis (ALS) including the upper motor neurons, lower motor neurons, and frontotemporal region of the brain, along with the muscles affected as a result",
          "credit": "<span class=\"int-own-work\" lang=\"en\">Own work</span>",
          "license": "cc-by-sa-4.0",
          "url": "https://commons.wikimedia.org/wiki/File:ALS_Affected_neurons_and_muscles.png"
        },
        {
          "title": "File:Physicist Stephen Hawking in Zero Gravity NASA.jpg",
          "author": "Jim Campbell/Aero-News Network",
          "description": "Noted physicist Stephen Hawking (center) enjoys zero gravity during a flight aboard a modified Boeing 727 aircraft owned by Zero Gravity Corp. (Zero G). Hawking, who suffered from amyotrophic lateral sclerosis (also known as Lou Gehrig's disease) is being rotated in air by (right) Peter Diamandis, founder of the Zero G Corp., and (left) Byron Lichtenberg, former shuttle payload specialist and now president of Zero G. Kneeling below Hawking is Nicola O'Brien, a nurse practitioner who was Hawking's aide. At the celebration of his 65th birthday on January 8, 2007, Hawking announced his plans for a zero-gravity flight to prepare for a sub-orbital space flight in 2009 on Virgin Galactic's space service.",
          "credit": "<a rel=\"nofollow\" class=\"external free\" href=\"https://www.flickr.com/photos/39735679@N00/475109138/\">https://www.flickr.com/photos/39735679@N00/475109138/</a> / <a rel=\"nofollow\" class=\"external free\" href=\"https://mediaarchive.ksc.nasa.gov/detail.cfm?mediaid=31873\">http://mediaarchive.ksc.nasa.gov/detail.cfm?mediaid=31873</a>",
          "license": "cc-by-3.0",
          "url": "https://commons.wikimedia.org/wiki/File:Physicist_Stephen_Hawking_in_Zero_Gravity_NASA.jpg"
        },
        {
          "title": "File:The National Amyotrophic Lateral Sclerosis Registry.webm",
          "author": "Centers for Disease Control and Prevention",
          "description": "Amyotrophic Lateral Sclerosis (ALS) is a progressively fatal disease of the nerve cells.  This video talks about the National ALS Registry created by the Agency for Toxic Substances and Disease Registry.  Learn more about the National ALS Registry at www.cdc.gov/als.\n<p>Comments on this video are allowed in accordance with our comment policy: <a rel=\"nofollow\" class=\"external free\" href=\"https://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html\">https://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html</a>\n</p>\nThis video can also be viewed at",
          "credit": "<p><bdi lang=\"en\" dir=\"ltr\"><a href=\"//commons.wikimedia.org/wiki/Commons:YouTube_files\" title=\"Commons:YouTube files\">YouTube</a>: <a rel=\"nofollow\" class=\"external text\" href=\"https://www.youtube.com/watch?v=rEe2LQ7XkvY\"><bdi lang=\"\">https://www.youtube.com/watch?v=rEe2LQ7XkvY</bdi></a> ‚Äì View/save archived versions on <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/*/https://www.youtube.com/watch?v=rEe2LQ7XkvY\">archive.org</a> and <a rel=\"nofollow\" class=\"external text\" href=\"https://archive.today/https://www.youtube.com/watch?v=rEe2LQ7XkvY\">archive.today</a></bdi>\n</p>\n<br>Playlist: <a rel=\"nofollow\" class=\"external free\" href=\"https://www.youtube.com/playlist?list=PLvrp9iOILTQaRWTguYiBvPlVB7R-88Wbq\">https://www.youtube.com/playlist?list=PLvrp9iOILTQaRWTguYiBvPlVB7R-88Wbq</a>",
          "license": "pd",
          "url": "https://commons.wikimedia.org/wiki/File:The_National_Amyotrophic_Lateral_Sclerosis_Registry.webm"
        }
      ],
      [],
      []
    ]
  },
  {
    "title": "Lymphatic propagation of Œ±-synuclein",
    "authors": [
      "Kiani, Lisa"
    ],
    "abstract": [
      ""
    ],
    "url": "https://doi.org/10.1038/s41582-023-00876-1",
    "journal": "Nature Reviews Neurology",
    "keywords": [
      "Parkinson's disease",
      "lymphatic system",
      "Œ±-synuclein"
    ],
    "caption": "üß† Exciting new research highlights the role of the brain's lymphatic system in the spread of mutant Œ±-synuclein, a protein linked to Parkinson's disease. Scientists found that these monomers travel via lymphatic vessels, forming fibrils similar to those seen in Parkinson's. This discovery could reveal new pathways for disease progression and potential therapeutic targets. üåüüî¨\n\nAs we continue to unlock the mysteries of the brain, insights like these are crucial in the fight against neurodegenerative diseases. Stay curious and keep exploring the incredible world of neuroscience! üåê‚ú®\n\n#Neuroscience #ParkinsonsDisease #BrainResearch #ScienceNews #Innovation #HealthRevolution",
    "images": [
      [
        {
          "title": "File:Parkinson's disease pathway (Homo sapiens).png",
          "author": "Alexander Pico, Kristina Hanspers, Egon Willighagen, Friederike Ehrhart, Eric Weitz, Martina Kutmon",
          "description": "Most people with Parkinson's disease have idiopathic Parkinson's disease (having no specific known cause). A small proportion of cases, however, can be attributed to known genetic factors. Mutations in specific genes have been conclusively shown to cause PD. These genes code for alpha-synuclein (SNCA), parkin (PRKN), leucine-rich repeat kinase 2 (LRRK2 or dardarin), PTEN-induced putative kinase 1 (PINK1), DJ-1 and ATP13A2.[4][22] In most cases, people with these mutations will develop PD. With the exception of LRRK2, however, they account for only a small minority of cases of PD.[4] The most extensively studied PD-related genes are SNCA and LRRK2. Mutations in genes including SNCA, LRRK2 and glucocerebrosidase (GBA) have been found to be risk factors for sporadic PD. The role of the SNCA gene is important in PD because the alpha-synuclein protein is the main component of Lewy bodies.[22] Missense mutations of the gene (in which a single nucleotide is changed), and duplications and triplications of the locus containing it have been found in different groups with familial PD. Mutations in LRRK2 are the most common known cause of familial and sporadic PD, accounting for approximately 5% of individuals with a family history of the disease and 3% of sporadic cases.",
          "credit": "<a rel=\"nofollow\" class=\"external free\" href=\"https://www.wikipathways.org/instance/WP2371\">https://www.wikipathways.org/instance/WP2371</a>",
          "license": "cc0",
          "url": "https://commons.wikimedia.org/wiki/File:Parkinson's_disease_pathway_(Homo_sapiens).png"
        },
        {
          "title": "File:Parkinson‚Äôs disease 1880s.jpg",
          "author": "William Gowers; retouched by <a href=\"//commons.wikimedia.org/wiki/User:Dustfreeworld\" title=\"User:Dustfreeworld\">User:Dustfreeworld</a>",
          "description": "Person with Parkinson‚Äôs disease. A retouched image from the drawings of a William Gowers. Color, brightness and size adjusted.\n<p><a class=\"external free\" href=\"https://commons.wikimedia.org/wiki/File:Drawings_of_a_Parkinson_patient_by_William_Gowers.jpg\">https://commons.wikimedia.org/wiki/File:Drawings_of_a_Parkinson_patient_by_William_Gowers.jpg</a>\n</p>\n<a rel=\"nofollow\" class=\"external free\" href=\"https://movementdisorders.onlinelibrary.wiley.com/doi/full/10.1002/mds.27965\">https://movementdisorders.onlinelibrary.wiley.com/doi/full/10.1002/mds.27965</a>",
          "credit": "<a href=\"//commons.wikimedia.org/wiki/File:Person_with_Parkinson_disease_BW.jpg\" title=\"File:Person with Parkinson disease BW.jpg\">File:Person_with_Parkinson_disease_BW.jpg</a>",
          "license": "pd",
          "url": "https://commons.wikimedia.org/wiki/File:Parkinson‚Äôs_disease_1880s.jpg"
        },
        {
          "title": "File:Basal ganglia without Parkinson's disease.png",
          "author": "<a href=\"//commons.wikimedia.org/wiki/User:Mikael_H%C3%A4ggstr%C3%B6m\" title=\"User:Mikael H√§ggstr√∂m\">Mikael H√§ggstr√∂m</a>, based on images by Andrew Gillies/User:Anaru and Patrick J. Lynch",
          "description": "Main circuits of the <a href=\"https://en.wikipedia.org/wiki/basal_ganglia\" class=\"extiw\" title=\"en:basal ganglia\">basal ganglia</a>, derived from <a href=\"//commons.wikimedia.org/wiki/File:Basal_ganglia_circuits.svg\" title=\"File:Basal ganglia circuits.svg\">Basal ganglia circuits.svg</a> without pars reticularis pathways for simplification. Picture shows 2 coronal slices that have been superimposed to include the involved basal ganglia structures. + and - signs at the point of the arrows indicate respectively whether the pathway is excitatory or inhibitory in effect. <font color=\"green\">Green arrows</font> refer to excitatory <a href=\"https://en.wikipedia.org/wiki/Glutamic_acid\" class=\"extiw\" title=\"en:Glutamic acid\">glutamatergic</a> pathways, <font color=\"red\">red arrows</font> refer to inhibitory <a href=\"https://en.wikipedia.org/wiki/gamma-Aminobutyric_acid\" class=\"extiw\" title=\"en:gamma-Aminobutyric acid\">GABAergic</a> pathways and <font color=\"turquoise\">turquoise arrows</font> refer to <a href=\"https://en.wikipedia.org/wiki/dopamine\" class=\"extiw\" title=\"en:dopamine\">dopaminergic</a> pathways that are excitatory on the direct pathway and inhibitory on the indirect pathway. Note that dis-inhibitory pathways in effect are excitatory on the feedback to the cortex, while dis-dis-inhibitory pathways in effect are inhibitory. <i>See <a href=\"https://en.wikipedia.org/wiki/Basal_ganglia#Connections\" class=\"extiw\" title=\"en:Basal ganglia\">en:Basal ganglia#Connections</a></i>",
          "credit": "<p>Made in Inkscape. Source images:\n</p>\n<ul class=\"gallery mw-gallery-traditional\">\n\t\t<li class=\"gallerybox\" style=\"width: 155px\">\n\t\t\t<div class=\"thumb\" style=\"width: 150px; height: 150px;\"><span typeof=\"mw:File\"><a href=\"//commons.wikimedia.org/wiki/File:Brain_human_lateral_view.svg\" class=\"mw-file-description\" title=\"Brain human lateral view.svg (By Patrick J. Lynch; Creative Commons Attribution-Share Alike license)\"><img alt=\"Brain human lateral view.svg (By Patrick J. Lynch; Creative Commons Attribution-Share Alike license)\" src=\"https://upload.wikimedia.org/wikipedia/commons/thumb/4/44/Brain_human_lateral_view.svg/120px-Brain_human_lateral_view.svg.png\" decoding=\"async\" width=\"101\" height=\"120\" class=\"mw-file-element\" srcset=\"https://upload.wikimedia.org/wikipedia/commons/thumb/4/44/Brain_human_lateral_view.svg/250px-Brain_human_lateral_view.svg.png 1.5x\" data-file-width=\"295\" data-file-height=\"351\"></a></span></div>\n\t\t\t<div class=\"gallerytext\">Brain human lateral view.svg (By Patrick J. Lynch; Creative Commons Attribution-Share Alike license)</div>\n\t\t</li>\n\t\t<li class=\"gallerybox\" style=\"width: 155px\">\n\t\t\t<div class=\"thumb\" style=\"width: 150px; height: 150px;\"><span typeof=\"mw:File\"><a href=\"//commons.wikimedia.org/wiki/File:Basal_ganglia.svg\" class=\"mw-file-description\" title=\"Basal ganglia.svg (Based on work by Andrew Gillies/User:Anaru; Creative Commons Attribution ShareAlike + GFDL license)\"><img alt=\"Basal ganglia.svg (Based on work by Andrew Gillies/User:Anaru; Creative Commons Attribution ShareAlike + GFDL license)\" src=\"https://upload.wikimedia.org/wikipedia/commons/thumb/3/3e/Basal_ganglia.svg/120px-Basal_ganglia.svg.png\" decoding=\"async\" width=\"120\" height=\"53\" class=\"mw-file-element\" srcset=\"https://upload.wikimedia.org/wikipedia/commons/thumb/3/3e/Basal_ganglia.svg/250px-Basal_ganglia.svg.png 1.5x\" data-file-width=\"800\" data-file-height=\"350\"></a></span></div>\n\t\t\t<div class=\"gallerytext\">Basal ganglia.svg (Based on work by Andrew Gillies/User:Anaru; Creative Commons Attribution ShareAlike + GFDL license)</div>\n\t\t</li>\n</ul>\n<p>Sources for circuits: \n</p>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.biochem.arizona.edu/classes/bioc462/462bh2008/462bhonorsprojects/462bhonors2004/navratilovaz/IntroPD.htm\">Introduction to Parkinson's Disease</a> By Zaneta Navratilova. Last updated: May 10, 2004. Modified from Nestler et. al, 2001, p. 306 and Ottley et. al, 1999.</li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://emedicine.medscape.com/article/1151267-media\">eMedicine &gt; Parkinson Disease: Multimedia</a> Author: Robert A Hauser. Coauthor(s): Rajesh Pahwa, Kelly E Lyons, Theresa McClain. Updated: Apr 27, 2010</li></ul>",
          "license": "cc-by-sa-3.0",
          "url": "https://commons.wikimedia.org/wiki/File:Basal_ganglia_without_Parkinson's_disease.png"
        },
        {
          "title": "File:Paralysis agitans-Male Parkinson's victim-1892 cropped.png",
          "author": "Albert Londe (1858-1917)",
          "description": "Full length view of a male with Parkinson's disease, showing a walking posture.",
          "credit": "<a rel=\"nofollow\" class=\"external free\" href=\"http://ihm.nlm.nih.gov/luna/servlet/detail/NLMNLM~1~1~101435392~139330:-Paralysis-agitans---Male-Parkinson\">http://ihm.nlm.nih.gov/luna/servlet/detail/NLMNLM~1~1~101435392~139330:-Paralysis-agitans---Male-Parkinson</a>",
          "license": "pd",
          "url": "https://commons.wikimedia.org/wiki/File:Paralysis_agitans-Male_Parkinson's_victim-1892_cropped.png"
        },
        {
          "title": "File:Histological sample of Substantia nigra in Parkinson's disease cropped.jpg",
          "author": "Werner CJ., Heyny-von Haussen R., Mall G., Wolf S. Proteome analysis of human substantia nigra in Parkinson's disease.. Proteome Sci. 6, 8. 2008. doi:10.1186/1477-5956-6-8. <a class=\"external mw-magiclink-pmid\" rel=\"nofollow\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18275612?dopt=Abstract\">PMID 18275612</a>.",
          "description": "Histological sample of Substantia nigra in Parkinson's disease. Left: SNpc neuron with a Lewy body, extracellular neuromelanin and pigment-laden macrophages. Haematoxylin/Eosin stain, 500√ó. Right: Alpha-synuclein-positive Lewy neurit, 400√ó.\n<p>Retouched by <a class=\"external text\" href=\"https://en.wikipedia.org/wiki/User:Dustfreeworld\">User:Dustfreeworld</a>. Cropped. Sharpness, colour and brightness, etc. adjusted. Added a black arrow pointing to the Lewy body.\n</p><p>Source:\n<a href=\"//commons.wikimedia.org/wiki/File:Histological_sample_of_Substantia_nigra_in_Parkinson%27s_disease.jpg\" title=\"File:Histological sample of Substantia nigra in Parkinson's disease.jpg\">File:Histological_sample_of_Substantia_nigra_in_Parkinson's_disease.jpg</a>\n<a rel=\"nofollow\" class=\"external free\" href=\"https://www.ncbi.nlm.nih.gov/pubmed/18275612\">https://www.ncbi.nlm.nih.gov/pubmed/18275612</a>\n</p>\nWerner CJ., Heyny-von Haussen R., Mall G., Wolf S. Proteome analysis of human substantia nigra in Parkinson's disease.. Proteome Sci. 6, 8. 2008. doi:10.1186/1477-5956-6-8. <a class=\"external mw-magiclink-pmid\" rel=\"nofollow\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18275612?dopt=Abstract\">PMID 18275612</a>.",
          "credit": "<a href=\"//commons.wikimedia.org/wiki/File:Histological_sample_of_Substantia_nigra_in_Parkinson%27s_disease.jpg\" title=\"File:Histological sample of Substantia nigra in Parkinson's disease.jpg\">File:Histological_sample_of_Substantia_nigra_in_Parkinson's_disease.jpg</a>     <a rel=\"nofollow\" class=\"external free\" href=\"https://www.ncbi.nlm.nih.gov/pubmed/18275612/\">https://www.ncbi.nlm.nih.gov/pubmed/18275612/</a>",
          "license": "cc-by-2.0",
          "url": "https://commons.wikimedia.org/wiki/File:Histological_sample_of_Substantia_nigra_in_Parkinson's_disease_cropped.jpg"
        },
        {
          "title": "File:Person with Parkinson disease BW.jpg",
          "author": "William Gowers",
          "description": "Person with Parkinson‚Äôs disease. A retouched image from the drawings of a William Gowers. Color adjusted. Darker tone.",
          "credit": "<a class=\"external free\" href=\"https://commons.wikimedia.org/wiki/File:Drawings_of_a_Parkinson_patient_by_William_Gowers.jpg\">https://commons.wikimedia.org/wiki/File:Drawings_of_a_Parkinson_patient_by_William_Gowers.jpg</a>",
          "license": "pd",
          "url": "https://commons.wikimedia.org/wiki/File:Person_with_Parkinson_disease_BW.jpg"
        }
      ],
      [
        {
          "title": "File:Maturation of the lymphatic system.jpg",
          "author": "<a href=\"//commons.wikimedia.org/w/index.php?title=User:SGUL_lymres&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"User:SGUL lymres (page does not exist)\">SGUL lymres</a>",
          "description": "At late gestation and postnatally, the lymphatic vessels disconnect from the venous system and the primitive lymphatic plexus remodels into initial capillaries and collecting vessels, to finally form a functional lymphatic vasculature. These processes will be finely orchestrated by e.g. EPHB4, FOXC2, GATA2, PIEZO1, FAT4 and gap junctions. Although the lymphatics in the 5.5cm pig embryo (A) have not yet developed valves, it is apparent how the primary lymphatic plexus is gradually spreading over the entire body and invades the skin. (B) Proposed models for the disconnection of the primary lymph sacs from the venous system. The ballooning model suggests that the PROX1-expressing cells (green) in the anterior wall of the cardinal vein (blue) wall undergo a process known as delamination, like the inflation of a balloon, to form the primitive lymph sacs. As the LEC progenitors balloon out they begin to express podoplanin, critical for the binding and aggregation of circulating platelets (orange) to form a clot that will mark the disconnection between systems; completed by E14 in mice. The budding model suggests that the LEC progenitors migrate out from the venous system as strings before coalescing to form lymph sacs, maintaining venous wall integrity, and preventing vascular leakage. (C) Disconnection of the lymphatic system in the jugular region by the development of lymphovenous valves. At the sites where the lymph sacs (LS) interact with the jugulo-subclavian vein junctions, lymphovenous valve (LVV) development begins. 1. LECs (yellow) and venous endothelial cells (VECs, red) interact to form the LVV. Mechanistically, LECs upregulate the expression of Prox1, Vegfr3 and Cx43 whereas VECs upregulate the expression of Foxc2, Gata2 and Cx37. 2. The aggregate of endothelial cells begins to delaminate and reorientate itself, invaginating into the vein. 3. As the LVV develops, the cells elongate and align themselves to the direction of venous blood flow. 4. An opening in the middle of the aggregate develops and the valves recruit mural cells (orange) into the space between the valvular endothelial cells and the LECs. In mice deleted for Ephb4 (boxed-in example) lymphovenous valve formation does not go through its natural progression ending up with defective valves which cannot prevent retrograde flow. As a result, the Ephb4 knockout (KO) embryos have blood-filled lymphatics. Arrows indicate direction of fluid flow. (D) Development of secondary lymphatic valves in the collector vessels. The presence of intraluminal lymphatic valves in the collecting vessels, will ensure the unidirectional flow of lymph through the mature lymphatic system. 1. Prior to the initiation of secondary lymphatic valve development, bifurcations in the developing lymphatic network lead to changes in lymph flow re-circulation (curved arrows). 2. In these specific sites (purple area), valve formation initiates by activation of mechanotransduction pathways triggering a cascade of transcription factor upregulation (e.g. Prox1, Foxc2, Gata2). 3. The flow-induced changes in molecular identity lead the cells to change shape and reorientate. 4. Extra-cellular matrix (ECM, red) is deposited, promoting the formation of a ring-like constriction and some of the cells start protruding toward the vessel lumen. 5. During maturation, those protrusions elongate, and a sinus develops. Smooth muscle cells (SMC) cover the collectors except in the valve region. In Foxc2 knockout (KO) mice (boxed-in example), lymphatic collector vessel maturation is impaired with malformed valves. Arrows indicate bi-directional lymph flow due to reflux.\n(Image credit: (A) Adapted ‚ÄòThe lymphatic system in the skin of a pig 5.5cm long‚Äô by F. Sabin, Wistar Institute of Anatomy and biology. Association of American Anatomists (1904). The American Journal of Anatomy).",
          "credit": "<span class=\"int-own-work\" lang=\"en\">Own work</span>",
          "license": "cc-by-sa-4.0",
          "url": "https://commons.wikimedia.org/wiki/File:Maturation_of_the_lymphatic_system.jpg"
        },
        {
          "title": "File:EB1911 - Lymphatic system - Fig. 1‚ÄîSuperficial Lymphatic Vessels and Glands.jpg",
          "author": "A. M. Paterson",
          "description": "Superficial Lymphatic Vessels and Glands. Œ±, Preauricular. Œ≤, Mastoid. Œ≥, Superficial cervical. Œ¥, Submaxillary. Œµ, Submental. Œ∂, Infraclavicular. Œ∑, Anterior axillary. Œ∏, Supratrochlear. Œπ, Antecubital. Œ∫, Inguinal. Œª, Superficial femoral",
          "credit": "<i>Encyclop√¶dia Britannica</i> (11th ed.), v. 17, 1911, \"Lymphatic System\" article, pp. 166‚Äì167. Modified from <a rel=\"nofollow\" class=\"external free\" href=\"https://www.gutenberg.org/files/43254/43254-h/43254-h.htm#ar63\">https://www.gutenberg.org/files/43254/43254-h/43254-h.htm#ar63</a>",
          "license": "pd",
          "url": "https://commons.wikimedia.org/wiki/File:EB1911_-_Lymphatic_system_-_Fig._1‚ÄîSuperficial_Lymphatic_Vessels_and_Glands.jpg"
        },
        {
          "title": "File:Lymphatic system2.png",
          "author": "NIH",
          "description": "The lymphatic system, lymph vessels and lymph nodes.",
          "credit": "NIH (a US government agency) image, <a rel=\"nofollow\" class=\"external text\" href=\"https://www.cancer.gov/images/Documents/6b08d7cc-2a8f-4d32-9a38-a5433aaf0794/lymph.gif\">http://www.cancer.gov/images/Documents/6b08d7cc-2a8f-4d32-9a38-a5433aaf0794/lymph.gif</a>",
          "license": "pd",
          "url": "https://commons.wikimedia.org/wiki/File:Lymphatic_system2.png"
        },
        {
          "title": "File:EB1911 - Lymphatic system - Fig. 2.‚ÄîDeep Lymphatic Glands and Vessels of the Thorax and Abdomen.jpg",
          "author": "A. M. Paterson",
          "description": "Deep Lymphatic Glands and Vessels of the Thorax and Abdomen. Afferent vessels are represented by continuous lines and efferent and interglandular vessels by dotted lines.",
          "credit": "<i>Encyclop√¶dia Britannica</i> (11th ed.), v. 17, 1911, \"Lymphatic System\" article, pp. 166‚Äì167. Modified from <a rel=\"nofollow\" class=\"external free\" href=\"https://www.gutenberg.org/files/43254/43254-h/43254-h.htm#ar63\">https://www.gutenberg.org/files/43254/43254-h/43254-h.htm#ar63</a>",
          "license": "pd",
          "url": "https://commons.wikimedia.org/wiki/File:EB1911_-_Lymphatic_system_-_Fig._2.‚ÄîDeep_Lymphatic_Glands_and_Vessels_of_the_Thorax_and_Abdomen.jpg"
        },
        {
          "title": "File:Expansion of the lymphatic vasculature.jpg",
          "author": "<a href=\"//commons.wikimedia.org/w/index.php?title=User:SGUL_lymres&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"User:SGUL lymres (page does not exist)\">SGUL lymres</a>",
          "description": "PROX1 expression leads to the downregulation of blood endothelial markers and the upregulation of vascular endothelial growth factor receptor 3 (VEGFR3) expression. At E10.5, these PROX1- and VEGFR3-expressing LECs (green) separate from the cardinal vein (blue) and migrate dorsally, guided by a molecular gradient of vascular endothelial growth factor C (VEGFC). Platelet aggregation at the points of LEC migration is shown (red). This initial phase of lymphatic expansion is absolutely dependent on VEGFR3-expressing LECs responding to VEGFC. Paracrine CCBE1 secretion at sites of lymphatic vessel growth promotes proteolytic cleavage of pro-VEGFC by the metalloprotease ADAMTS3. This activates and mobilizes a fully mature VEGFC molecule that on binding to VEGFR3 can activate autophosphorylation and downstream signaling. It is thought that CCBE1 binds to the extracellular matrix (ECM) while VEGFC cleavage may occur on the lymphatic endothelial cell surface. Key transcription factors like GATA2 and HHEX regulate VEGFR3 expression and the PROX1-VEGFR3 autoregulatory feedback remains important during the vascular expansion process. At E11.5 primordial lymph sacs are formed. Drawing of a human embryo (at gestational week 6 ‚Äì 7, head not shown) displaying the first primitive lymphatic structures seen as six primary lymph sacs in green (veins in blue). The jugular lymph sacs develop around the upper jugular vein, the retroperitoneal lymph sac and cisterna chyli in the central segment of the embryo and the two posterior lymph sacs around the lower limbs near the iliac veins.",
          "credit": "<span class=\"int-own-work\" lang=\"en\">Own work</span>",
          "license": "cc-by-sa-4.0",
          "url": "https://commons.wikimedia.org/wiki/File:Expansion_of_the_lymphatic_vasculature.jpg"
        }
      ],
      [
        {
          "title": "File:Hypothetical model for the pathological interaction between Œ±-synuclein and nanoplastic contaminants in neurons.jpg",
          "author": "Authors of the study: Zhiyong Liu <a rel=\"nofollow\" class=\"external free\" href=\"https://orcid.org/0000-0002-2959-5189\">https://orcid.org/0000-0002-2959-5189</a>, Arpine Sokratian <a rel=\"nofollow\" class=\"external free\" href=\"https://orcid.org/0000-0001-6654-5773\">https://orcid.org/0000-0001-6654-5773</a>, Addison M. Duda <a rel=\"nofollow\" class=\"external free\" href=\"https://orcid.org/0000-0002-8116-4714\">https://orcid.org/0000-0002-8116-4714</a>, Enquan Xu, Christina Stanhope, Amber Fu <a rel=\"nofollow\" class=\"external free\" href=\"https://orcid.org/0009-0008-0898-9067\">https://orcid.org/0009-0008-0898-9067</a>, Samuel Strader <a rel=\"nofollow\" class=\"external free\" href=\"https://orcid.org/0000-0003-4417-3707\">https://orcid.org/0000-0003-4417-3707</a>, Huizhong Li <a rel=\"nofollow\" class=\"external free\" href=\"https://orcid.org/0009-0004-1228-0721\">https://orcid.org/0009-0004-1228-0721</a>, Yuan Yuan <a rel=\"nofollow\" class=\"external free\" href=\"https://orcid.org/0009-0002-3810-6487\">https://orcid.org/0009-0002-3810-6487</a>, Benjamin G. Bobay <a rel=\"nofollow\" class=\"external free\" href=\"https://orcid.org/0000-0003-4775-3686\">https://orcid.org/0000-0003-4775-3686</a>, Joana Sipe <a rel=\"nofollow\" class=\"external free\" href=\"https://orcid.org/0000-0001-5602-0922\">https://orcid.org/0000-0001-5602-0922</a>, Ketty Bai <a rel=\"nofollow\" class=\"external free\" href=\"https://orcid.org/0000-0002-9807-888X\">https://orcid.org/0000-0002-9807-888X</a>, Iben Lundgaard <a rel=\"nofollow\" class=\"external free\" href=\"https://orcid.org/0000-0001-9613-3892\">https://orcid.org/0000-0001-9613-3892</a>, Na Liu <a rel=\"nofollow\" class=\"external free\" href=\"https://orcid.org/0000-0002-3140-795X\">https://orcid.org/0000-0002-3140-795X</a>, Belinda Hernandez <a rel=\"nofollow\" class=\"external free\" href=\"https://orcid.org/0000-0001-5017-1447\">https://orcid.org/0000-0001-5017-1447</a>, Catherine Bowes Rickman, Sara E. Miller, and Andrew B. West <a rel=\"nofollow\" class=\"external free\" href=\"https://orcid.org/0000-0002-3034-4061\">https://orcid.org/0000-0002-3034-4061</a>",
          "description": "\"Nanoparticles that have the intrinsic capacity to disrupt and cross the blood-brain barrier, such as small charged polystyrene particles, may come into contact with neurons that express high levels of Œ±-synuclein and can harbor aggregates in disease. Peripheral cells susceptible to Œ±-synuclein aggregation and outside of the blood-brain barrier (e.g., vagal neurons) may also come into contact with nanoplastic contaminants. Both Œ±-synuclein fibrils and nanoplastics can enter the endolysosomal compartment in neurons through a clathrin-dependent endocytosis process. A healthy lysosome might fully degrade an Œ±-synuclein aggregate. However, if a lysosome is impaired by nanoplastic particles, Œ±-synuclein aggregates might not degrade and endogenous Œ±-synuclein trafficked to the lysosome may inadvertently spur the formation of new Œ±-synuclein fibrils through the potent pro-aggregation catalytic action of nanoplastics. This feedforward pathway highlights a two-part proposed mechanism whereby nanoplastic contaminants may accelerate the formation of misfolded Œ±-synuclein in the endolysosome compartment and simultaneously impair the degradative action of the organelles (i.e., lysosomes) primarily responsible for their clearance.\"",
          "credit": "<a rel=\"nofollow\" class=\"external free\" href=\"https://www.science.org/doi/10.1126/sciadv.adi8716\">https://www.science.org/doi/10.1126/sciadv.adi8716</a>",
          "license": "cc-by-4.0",
          "url": "https://commons.wikimedia.org/wiki/File:Hypothetical_model_for_the_pathological_interaction_between_Œ±-synuclein_and_nanoplastic_contaminants_in_neurons.jpg"
        },
        {
          "title": "File:Elevated-Œ±-synuclein-caused-by-SNCA-gene-triplication-impairs-neuronal-differentiation-and-cddis2015318x10.ogv",
          "author": "Oliveira L, Falomir-Lockhart L, Botelho M, Lin K, Wales P, Koch J, Gerhardt E, Taschenberger H, Outeiro T, Lingor P, Sch√ºle B, Arndt-Jovin D, Jovin T",
          "description": null,
          "credit": "<a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670926/bin/cddis2015318x10.mov\">Supplementary Movie 1</a> from <cite style=\"font-style:normal\">Oliveira L, Falomir-Lockhart L, Botelho M, Lin K, Wales P, Koch J, Gerhardt E, Taschenberger H, Outeiro T, Lingor P, Sch√ºle B, Arndt-Jovin D, Jovin T (2015). \"<a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670926\">Elevated Œ±-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson's patient-derived induced pluripotent stem cells</a>\". <i>Cell Death &amp; Disease</i>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/Digital_object_identifier\" class=\"extiw\" title=\"en:Digital object identifier\">DOI</a></span>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038/cddis.2015.318\">10.1038/cddis.2015.318</a>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/PubMed\" class=\"extiw\" title=\"en:PubMed\"><span lang=\"en\" dir=\"ltr\">PMID</span></a></span> <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pubmed/26610207\">26610207</a>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/PubMed_Central\" class=\"extiw\" title=\"en:PubMed Central\"><span lang=\"en\" dir=\"ltr\">PMC</span></a></span>: <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670926\">4670926</a>.</cite>",
          "license": "cc-by-4.0",
          "url": "https://commons.wikimedia.org/wiki/File:Elevated-Œ±-synuclein-caused-by-SNCA-gene-triplication-impairs-neuronal-differentiation-and-cddis2015318x10.ogv"
        },
        {
          "title": "File:Membrane-Permeabilization-by-Oligomeric-Œ±-Synuclein-In-Search-of-the-Mechanism-pone.0014292.s001.ogv",
          "author": "van Rooijen B, Claessens M, Subramaniam V",
          "description": "Confocal microscopy movie of POPG GUVs filled with the dye HPTS (green) in a flow chamber. The quencher DPX was present on the outside of the vesicles. The GUV membrane was stained with DOPE-Rhodamine (red). An aliquot of oligomers was introduced into the chamber (top of the image frames), and imaging was continued.",
          "credit": "Movie S1 from <cite style=\"font-style:normal\">van Rooijen B, Claessens M, Subramaniam V (2010). \"<a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001441\">Membrane Permeabilization by Oligomeric Œ±-Synuclein: In Search of the Mechanism</a>\". <i>PLOS ONE</i>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/Digital_object_identifier\" class=\"extiw\" title=\"en:Digital object identifier\">DOI</a></span>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1371/journal.pone.0014292\">10.1371/journal.pone.0014292</a>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/PubMed\" class=\"extiw\" title=\"en:PubMed\"><span lang=\"en\" dir=\"ltr\">PMID</span></a></span> <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pubmed/21179192\">21179192</a>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/PubMed_Central\" class=\"extiw\" title=\"en:PubMed Central\"><span lang=\"en\" dir=\"ltr\">PMC</span></a></span>: <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001441\">3001441</a>.</cite>",
          "license": "cc-by-2.5",
          "url": "https://commons.wikimedia.org/wiki/File:Membrane-Permeabilization-by-Oligomeric-Œ±-Synuclein-In-Search-of-the-Mechanism-pone.0014292.s001.ogv"
        },
        {
          "title": "File:Astrocytic-expression-of-Parkinson's-disease-related-A53T-Œ±-synuclein-causes-neurodegeneration-in-1756-6606-3-12-S4.ogv",
          "author": "Gu X, Long C, Sun L, Xie C, Lin X, Cai H",
          "description": "Symptomatic A53T mice were only able to run at the speed of 5 cm/s. The first mouse showed paralysis in both forelimbs. The second mouse displayed paralysis in the left forelimb and in both hindlimbs.",
          "credit": "<cite style=\"font-style:normal\">Gu X, Long C, Sun L, Xie C, Lin X, Cai H (2010). \"<a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873589\">Astrocytic expression of Parkinson's disease-related A53T Œ±-synuclein causes neurodegeneration in mice</a>\". <i>Molecular Brain</i>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/Digital_object_identifier\" class=\"extiw\" title=\"en:Digital object identifier\">DOI</a></span>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1186/1756-6606-3-12\">10.1186/1756-6606-3-12</a>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/PubMed\" class=\"extiw\" title=\"en:PubMed\"><span lang=\"en\" dir=\"ltr\">PMID</span></a></span> <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pubmed/20409326\">20409326</a>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/PubMed_Central\" class=\"extiw\" title=\"en:PubMed Central\"><span lang=\"en\" dir=\"ltr\">PMC</span></a></span>: <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873589\">2873589</a>.</cite>",
          "license": "cc-by-2.0",
          "url": "https://commons.wikimedia.org/wiki/File:Astrocytic-expression-of-Parkinson's-disease-related-A53T-Œ±-synuclein-causes-neurodegeneration-in-1756-6606-3-12-S4.ogv"
        },
        {
          "title": "File:Astrocytic-expression-of-Parkinson's-disease-related-A53T-Œ±-synuclein-causes-neurodegeneration-in-1756-6606-3-12-S5.ogv",
          "author": "Gu X, Long C, Sun L, Xie C, Lin X, Cai H",
          "description": "A53T mice developed rapid progression of paralysis in four limbs. This mouse was able to run at the speed of 5 cm/s on postnatal day 65 (P65), but 2 cm/s on P70. The right forelimb started to show paralysis on P71 and then the left forelimb was affected on P73.",
          "credit": "<cite style=\"font-style:normal\">Gu X, Long C, Sun L, Xie C, Lin X, Cai H (2010). \"<a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873589\">Astrocytic expression of Parkinson's disease-related A53T Œ±-synuclein causes neurodegeneration in mice</a>\". <i>Molecular Brain</i>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/Digital_object_identifier\" class=\"extiw\" title=\"en:Digital object identifier\">DOI</a></span>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1186/1756-6606-3-12\">10.1186/1756-6606-3-12</a>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/PubMed\" class=\"extiw\" title=\"en:PubMed\"><span lang=\"en\" dir=\"ltr\">PMID</span></a></span> <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pubmed/20409326\">20409326</a>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/PubMed_Central\" class=\"extiw\" title=\"en:PubMed Central\"><span lang=\"en\" dir=\"ltr\">PMC</span></a></span>: <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873589\">2873589</a>.</cite>",
          "license": "cc-by-2.0",
          "url": "https://commons.wikimedia.org/wiki/File:Astrocytic-expression-of-Parkinson's-disease-related-A53T-Œ±-synuclein-causes-neurodegeneration-in-1756-6606-3-12-S5.ogv"
        },
        {
          "title": "File:Œë-synuclein-transfer-through-tunneling-nanotubes-occurs-in-SH-SY5Y-cells-and-primary-brain-srep42984-s3.ogv",
          "author": "Dieriks B, Park T, Fourie C, Faull R, Dragunow M, Curtis M",
          "description": "Supplementary Movie 2",
          "credit": "<a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322400/bin/srep42984-s3.mov\">Video file</a> from <cite style=\"font-style:normal\">Dieriks B, Park T, Fourie C, Faull R, Dragunow M, Curtis M (2017). \"<a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322400\">Œ±-synuclein transfer through tunneling nanotubes occurs in SH-SY5Y cells and primary brain pericytes from Parkinson‚Äôs disease patients</a>\". <i>Scientific Reports</i>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/Digital_object_identifier\" class=\"extiw\" title=\"en:Digital object identifier\">DOI</a></span>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038/srep42984\">10.1038/srep42984</a>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/PubMed\" class=\"extiw\" title=\"en:PubMed\"><span lang=\"en\" dir=\"ltr\">PMID</span></a></span> <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pubmed/28230073\">28230073</a>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/PubMed_Central\" class=\"extiw\" title=\"en:PubMed Central\"><span lang=\"en\" dir=\"ltr\">PMC</span></a></span>: <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322400\">5322400</a>.</cite>",
          "license": "cc-by-4.0",
          "url": "https://commons.wikimedia.org/wiki/File:Œë-synuclein-transfer-through-tunneling-nanotubes-occurs-in-SH-SY5Y-cells-and-primary-brain-srep42984-s3.ogv"
        },
        {
          "title": "File:Œë-synuclein-transfer-through-tunneling-nanotubes-occurs-in-SH-SY5Y-cells-and-primary-brain-srep42984-s2.ogv",
          "author": "Dieriks B, Park T, Fourie C, Faull R, Dragunow M, Curtis M",
          "description": "Supplementary Movie 1",
          "credit": "<a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322400/bin/srep42984-s2.mov\">Video file</a> from <cite style=\"font-style:normal\">Dieriks B, Park T, Fourie C, Faull R, Dragunow M, Curtis M (2017). \"<a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322400\">Œ±-synuclein transfer through tunneling nanotubes occurs in SH-SY5Y cells and primary brain pericytes from Parkinson‚Äôs disease patients</a>\". <i>Scientific Reports</i>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/Digital_object_identifier\" class=\"extiw\" title=\"en:Digital object identifier\">DOI</a></span>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038/srep42984\">10.1038/srep42984</a>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/PubMed\" class=\"extiw\" title=\"en:PubMed\"><span lang=\"en\" dir=\"ltr\">PMID</span></a></span> <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pubmed/28230073\">28230073</a>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/PubMed_Central\" class=\"extiw\" title=\"en:PubMed Central\"><span lang=\"en\" dir=\"ltr\">PMC</span></a></span>: <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322400\">5322400</a>.</cite>",
          "license": "cc-by-4.0",
          "url": "https://commons.wikimedia.org/wiki/File:Œë-synuclein-transfer-through-tunneling-nanotubes-occurs-in-SH-SY5Y-cells-and-primary-brain-srep42984-s2.ogv"
        },
        {
          "title": "File:Astrocytic-expression-of-Parkinson's-disease-related-A53T-Œ±-synuclein-causes-neurodegeneration-in-1756-6606-3-12-S3.ogv",
          "author": "Gu X, Long C, Sun L, Xie C, Lin X, Cai H",
          "description": "The TreadScan Gait Analysis System (Clever Sys, Reston, VA) was used to record the gait information of A53T mice. Each mouse was placed on the belt of treadmill unit. The movement of each paw was recorded with the treadmill running at 17 cm/s, 5 cm/s and 2 cm/s, respectively [54]. A representative control nTg mouse was running on the treadmill with the speed set at 17 cm/s. The later part of movie was replayed four times slower than the first part to better visualize the placement of each paw on the belt.",
          "credit": "<cite style=\"font-style:normal\">Gu X, Long C, Sun L, Xie C, Lin X, Cai H (2010). \"<a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873589\">Astrocytic expression of Parkinson's disease-related A53T Œ±-synuclein causes neurodegeneration in mice</a>\". <i>Molecular Brain</i>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/Digital_object_identifier\" class=\"extiw\" title=\"en:Digital object identifier\">DOI</a></span>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1186/1756-6606-3-12\">10.1186/1756-6606-3-12</a>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/PubMed\" class=\"extiw\" title=\"en:PubMed\"><span lang=\"en\" dir=\"ltr\">PMID</span></a></span> <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pubmed/20409326\">20409326</a>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/PubMed_Central\" class=\"extiw\" title=\"en:PubMed Central\"><span lang=\"en\" dir=\"ltr\">PMC</span></a></span>: <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873589\">2873589</a>.</cite>",
          "license": "cc-by-2.0",
          "url": "https://commons.wikimedia.org/wiki/File:Astrocytic-expression-of-Parkinson's-disease-related-A53T-Œ±-synuclein-causes-neurodegeneration-in-1756-6606-3-12-S3.ogv"
        },
        {
          "title": "File:Events in alpha synuclein toxicity.jpg",
          "author": "Mark R Cookson",
          "description": "Events in Œ±-synuclein toxicity. The central panel shows the major pathway for protein aggregation. Monomeric Œ±-synuclein is natively unfolded in solution but can also bind to membranes in an Œ±-helical form. It seems likely that these two species exist in equilibrium within the cell, although this is unproven. From in vitro work, it is clear that unfolded monomer can aggregate first into small oligomeric species that can be stabilized by Œ≤-sheet-like interactions and then into higher molecular weight insoluble fibrils. In a cellular context, there is some evidence that the presence of lipids can promote oligomer formation: Œ±-synuclein can also form annular, pore-like structures that interact with membranes. The deposition of Œ±-synuclein into pathological structures such as Lewy bodies is probably a late event that occurs in some neurons. On the left hand side are some of the known modifiers of this process. Electrical activity in neurons changes the association of Œ±-synuclein with vesicles and may also stimulate polo-like kinase 2 (PLK2), which has been shown to phosphorylate Œ±-synuclein at Ser129. Other kinases have also been proposed to be involved. As well as phosphorylation, truncation through proteases such as calpains, and nitration, probably through nitric oxide (NO) or other reactive nitrogen species that are present during inflammation, all modify synuclein such that it has a higher tendency to aggregate. The addition of ubiquitin (shown as a black spot) to Lewy bodies is probably a secondary process to deposition. On the right are some of the proposed cellular targets for Œ±-synuclein mediated toxicity, which include (from top to bottom) ER-golgi transport, synaptic vesicles, mitochondria and lysosomes and other proteolytic machinery. In each of these cases, it is proposed that Œ±-synuclein has detrimental effects, listed below each arrow, although at this time it is not clear if any of these are either necessary or sufficient for toxicity in neurons. Cookson Molecular Neurodegeneration 2009 4:9   <a href=\"//doi.org/10.1186/1750-1326-4-9\" class=\"extiw\" title=\"doi:10.1186/1750-1326-4-9\">doi:10.1186/1750-1326-4-9</a>",
          "credit": "<a rel=\"nofollow\" class=\"external text\" href=\"http://www.molecularneurodegeneration.com/content/4/1/9\">Œ±-Synuclein and neuronal cell death</a>",
          "license": "cc-by-2.0",
          "url": "https://commons.wikimedia.org/wiki/File:Events_in_alpha_synuclein_toxicity.jpg"
        }
      ]
    ]
  },
  {
    "title": "Microglia, spreaders of AŒ≤ seeds",
    "authors": [
      "Fyfe, Ian"
    ],
    "abstract": [
      ""
    ],
    "url": "https://doi.org/10.1038/s41582-021-00604-7",
    "journal": "Nature Reviews Neurology",
    "keywords": [
      "Alzheimer's disease",
      "microglia",
      "amyloid-beta"
    ],
    "caption": "üß† Exciting new research highlights the vital role of microglia in the spread of amyloid-Œ≤ (AŒ≤) pathology in Alzheimer's disease. Published in Nature Neuroscience, these findings suggest that microglia, known for spreading tau proteins, might also transport AŒ≤, offering a fresh perspective on their involvement in Alzheimer's. This discovery opens up potential new therapeutic targets, paving the way for innovative treatments. üåü\n\nAs we continue to unravel the complexities of neurodegenerative diseases, understanding the mechanisms of AŒ≤ propagation is crucial. This research underscores the importance of targeting microglial activity in the fight against Alzheimer's, potentially leading to breakthroughs in slowing or halting disease progression. üî¨\n\nStay tuned for more updates on how these insights could revolutionize Alzheimer's treatment! \n\n#Neuroscience #Alzheimers #Microglia #Research #BrainHealth #ScienceNews",
    "images": [
      [
        {
          "title": "File:Alzheimer's disease brain comparison.jpg",
          "author": "<ul><li>derivative work: <a href=\"//commons.wikimedia.org/wiki/User:Garrondo\" title=\"User:Garrondo\">Garrondo</a> (<a href=\"//commons.wikimedia.org/wiki/User_talk:Garrondo\" title=\"User talk:Garrondo\">talk</a>)</li>\n<li><a href=\"//commons.wikimedia.org/wiki/File:SEVERESLICE_HIGH.JPG\" class=\"mw-redirect\" title=\"File:SEVERESLICE HIGH.JPG\">SEVERESLICE_HIGH.JPG</a>: ADEAR:  \"Alzheimer's Disease Education and Referral Center, a service of the National Institute on Aging.\"</li>\n<li><a href=\"//commons.wikimedia.org/wiki/File:PRECLINICALSLICE_HIGH.JPG\" class=\"mw-redirect\" title=\"File:PRECLINICALSLICE HIGH.JPG\">PRECLINICALSLICE_HIGH.JPG</a>: ADEAR:  \"Alzheimer's Disease Education and Referral Center, a service of the National Institute on Aging.\"</li></ul>",
          "description": "Diagram of a normal brain",
          "credit": "<ul><li><a href=\"//commons.wikimedia.org/wiki/File:SEVERESLICE_HIGH.JPG\" class=\"mw-redirect\" title=\"File:SEVERESLICE HIGH.JPG\">SEVERESLICE_HIGH.JPG</a></li>\n<li><a href=\"//commons.wikimedia.org/wiki/File:PRECLINICALSLICE_HIGH.JPG\" class=\"mw-redirect\" title=\"File:PRECLINICALSLICE HIGH.JPG\">PRECLINICALSLICE_HIGH.JPG</a></li></ul>",
          "license": "pd",
          "url": "https://commons.wikimedia.org/wiki/File:Alzheimer's_disease_brain_comparison.jpg"
        },
        {
          "title": "File:Histopathology of granulovacuolar degeneration in Alzheimer's disease - annotated.jpg",
          "author": "<figure typeof=\"mw:File/Thumb\"><a href=\"//commons.wikimedia.org/wiki/File:Mikael_H%C3%A4ggstr%C3%B6m_at_pathology_in_2019_(crop).jpg\" class=\"mw-file-description\"><img src=\"https://upload.wikimedia.org/wikipedia/commons/thumb/f/f1/Mikael_H%C3%A4ggstr%C3%B6m_at_pathology_in_2019_%28crop%29.jpg/250px-Mikael_H%C3%A4ggstr%C3%B6m_at_pathology_in_2019_%28crop%29.jpg\" decoding=\"async\" width=\"135\" height=\"159\" class=\"mw-file-element\" srcset=\"https://upload.wikimedia.org/wikipedia/commons/thumb/f/f1/Mikael_H%C3%A4ggstr%C3%B6m_at_pathology_in_2019_%28crop%29.jpg/330px-Mikael_H%C3%A4ggstr%C3%B6m_at_pathology_in_2019_%28crop%29.jpg 2x\" data-file-width=\"1439\" data-file-height=\"1697\"></a><figcaption><a href=\"//commons.wikimedia.org/wiki/User:Mikael_H%C3%A4ggstr%C3%B6m\" title=\"User:Mikael H√§ggstr√∂m\">Mikael H√§ggstr√∂m</a>, <a href=\"https://en.wikipedia.org/wiki/Medical_Doctor\" class=\"extiw\" title=\"en:Medical Doctor\">M.D.</a> <a href=\"//commons.wikimedia.org/wiki/Mikael_H%C3%A4ggstr%C3%B6m\" class=\"mw-redirect\" title=\"Mikael H√§ggstr√∂m\">Author info</a><br> - <a href=\"//commons.wikimedia.org/wiki/User:Mikael_H%C3%A4ggstr%C3%B6m#Reusing_images\" title=\"User:Mikael H√§ggstr√∂m\">Reusing images</a><br>- Conflicts of interest:<br>¬† None</figcaption></figure>\n<a href=\"//commons.wikimedia.org/wiki/User:Mikael_H%C3%A4ggstr%C3%B6m\" title=\"User:Mikael H√§ggstr√∂m\">Mikael H√§ggstr√∂m</a>, <a href=\"https://en.wikipedia.org/wiki/Medical_Doctor\" class=\"extiw\" title=\"en:Medical Doctor\">M.D.</a><br><b>Consent note</b>: Consent from the patient or patient's relatives is regarded as redundant, because of absence of identifiable features (<a rel=\"nofollow\" class=\"external text\" href=\"https://research.ucr.edu/ori/committees/irb-clin/hipaa/hipaa-phi-identifiers\">List of HIPAA identifiers</a>) in the media and case information (<a rel=\"nofollow\" class=\"external text\" href=\"https://research.ucr.edu/media/34266/hipaa_case_reports.pdf\">See also HIPAA case reports guidance</a>).",
          "description": "Histopathology of granulovacuolar degeneration in the <a href=\"https://en.wikipedia.org/wiki/hippocampus\" class=\"extiw\" title=\"en:hippocampus\">hippocampus</a> in <a href=\"https://en.wikipedia.org/wiki/Alzheimer%27s_disease\" class=\"extiw\" title=\"en:Alzheimer's disease\">Alzheimer's disease</a>. H&amp;E stain.",
          "credit": "<span class=\"int-own-work\" lang=\"en\">Own work</span>",
          "license": "cc0",
          "url": "https://commons.wikimedia.org/wiki/File:Histopathology_of_granulovacuolar_degeneration_in_Alzheimer's_disease_-_annotated.jpg"
        },
        {
          "title": "File:Alzheimer's disease brain comparison-zh.jpg",
          "author": "<ul><li><a href=\"//commons.wikimedia.org/wiki/File:Alzheimer%27s_disease_brain_comparison.jpg\" title=\"File:Alzheimer's disease brain comparison.jpg\">File:Alzheimer's disease brain comparison.jpg</a>: *derivative work: <a href=\"//commons.wikimedia.org/wiki/User:Garrondo\" title=\"User:Garrondo\">Garrondo</a> (<a href=\"//commons.wikimedia.org/wiki/User_talk:Garrondo\" title=\"User talk:Garrondo\">talk</a>)</li>\n<li><a href=\"//commons.wikimedia.org/wiki/File:SEVERESLICE_HIGH.JPG\" class=\"mw-redirect\" title=\"File:SEVERESLICE HIGH.JPG\">SEVERESLICE_HIGH.JPG</a>: ADEAR:  \"Alzheimer's Disease Education and Referral Center, a service of the National Institute on Aging.\"</li>\n<li><a href=\"//commons.wikimedia.org/wiki/File:PRECLINICALSLICE_HIGH.JPG\" class=\"mw-redirect\" title=\"File:PRECLINICALSLICE HIGH.JPG\">PRECLINICALSLICE_HIGH.JPG</a>: ADEAR:  \"Alzheimer's Disease Education and Referral Center, a service of the National Institute on Aging.\"</li></ul>",
          "description": "Diagram of a normal brain",
          "credit": "This file was derived from:  <a href=\"//commons.wikimedia.org/wiki/File:Alzheimer%27s_disease_brain_comparison.jpg\" title=\"File:Alzheimer's disease brain comparison.jpg\">Alzheimer's disease brain comparison.jpg</a>:¬†<span typeof=\"mw:File\"><a href=\"//commons.wikimedia.org/wiki/File:Alzheimer%27s_disease_brain_comparison.jpg\" class=\"mw-file-description\"><img src=\"https://upload.wikimedia.org/wikipedia/commons/thumb/a/a5/Alzheimer%27s_disease_brain_comparison.jpg/60px-Alzheimer%27s_disease_brain_comparison.jpg\" decoding=\"async\" width=\"50\" height=\"23\" class=\"mw-file-element\" srcset=\"https://upload.wikimedia.org/wikipedia/commons/thumb/a/a5/Alzheimer%27s_disease_brain_comparison.jpg/120px-Alzheimer%27s_disease_brain_comparison.jpg 1.5x\" data-file-width=\"3984\" data-file-height=\"1800\"></a></span><br>",
          "license": "pd",
          "url": "https://commons.wikimedia.org/wiki/File:Alzheimer's_disease_brain_comparison-zh.jpg"
        },
        {
          "title": "File:Histopathology of neurofibrillary tangles in Alzheimer's disease - annotated.jpg",
          "author": "<figure typeof=\"mw:File/Thumb\"><a href=\"//commons.wikimedia.org/wiki/File:Mikael_H%C3%A4ggstr%C3%B6m_at_pathology_in_2019_(crop).jpg\" class=\"mw-file-description\"><img src=\"https://upload.wikimedia.org/wikipedia/commons/thumb/f/f1/Mikael_H%C3%A4ggstr%C3%B6m_at_pathology_in_2019_%28crop%29.jpg/250px-Mikael_H%C3%A4ggstr%C3%B6m_at_pathology_in_2019_%28crop%29.jpg\" decoding=\"async\" width=\"135\" height=\"159\" class=\"mw-file-element\" srcset=\"https://upload.wikimedia.org/wikipedia/commons/thumb/f/f1/Mikael_H%C3%A4ggstr%C3%B6m_at_pathology_in_2019_%28crop%29.jpg/330px-Mikael_H%C3%A4ggstr%C3%B6m_at_pathology_in_2019_%28crop%29.jpg 2x\" data-file-width=\"1439\" data-file-height=\"1697\"></a><figcaption><a href=\"//commons.wikimedia.org/wiki/User:Mikael_H%C3%A4ggstr%C3%B6m\" title=\"User:Mikael H√§ggstr√∂m\">Mikael H√§ggstr√∂m</a>, <a href=\"https://en.wikipedia.org/wiki/Medical_Doctor\" class=\"extiw\" title=\"en:Medical Doctor\">M.D.</a> <a href=\"//commons.wikimedia.org/wiki/Mikael_H%C3%A4ggstr%C3%B6m\" class=\"mw-redirect\" title=\"Mikael H√§ggstr√∂m\">Author info</a><br> - <a href=\"//commons.wikimedia.org/wiki/User:Mikael_H%C3%A4ggstr%C3%B6m#Reusing_images\" title=\"User:Mikael H√§ggstr√∂m\">Reusing images</a><br>- Conflicts of interest:<br>¬† None</figcaption></figure>\n<a href=\"//commons.wikimedia.org/wiki/User:Mikael_H%C3%A4ggstr%C3%B6m\" title=\"User:Mikael H√§ggstr√∂m\">Mikael H√§ggstr√∂m</a>, <a href=\"https://en.wikipedia.org/wiki/Medical_Doctor\" class=\"extiw\" title=\"en:Medical Doctor\">M.D.</a><br><b>Consent note</b>: Consent from the patient or patient's relatives is regarded as redundant, because of absence of identifiable features (<a rel=\"nofollow\" class=\"external text\" href=\"https://research.ucr.edu/ori/committees/irb-clin/hipaa/hipaa-phi-identifiers\">List of HIPAA identifiers</a>) in the media and case information (<a rel=\"nofollow\" class=\"external text\" href=\"https://research.ucr.edu/media/34266/hipaa_case_reports.pdf\">See also HIPAA case reports guidance</a>).",
          "description": "Histopathology of neurofibrillary tangles in the <a href=\"https://en.wikipedia.org/wiki/hippocampus\" class=\"extiw\" title=\"en:hippocampus\">hippocampus</a> in <a href=\"https://en.wikipedia.org/wiki/Alzheimer%27s_disease\" class=\"extiw\" title=\"en:Alzheimer's disease\">Alzheimer's disease</a>. H&amp;E stain.",
          "credit": "<span class=\"int-own-work\" lang=\"en\">Own work</span>",
          "license": "cc0",
          "url": "https://commons.wikimedia.org/wiki/File:Histopathology_of_neurofibrillary_tangles_in_Alzheimer's_disease_-_annotated.jpg"
        },
        {
          "title": "File:Histopathology of amyloid plaque in Alzheimer's disease - annotated.jpg",
          "author": "<figure typeof=\"mw:File/Thumb\"><a href=\"//commons.wikimedia.org/wiki/File:Mikael_H%C3%A4ggstr%C3%B6m_at_pathology_in_2019_(crop).jpg\" class=\"mw-file-description\"><img src=\"https://upload.wikimedia.org/wikipedia/commons/thumb/f/f1/Mikael_H%C3%A4ggstr%C3%B6m_at_pathology_in_2019_%28crop%29.jpg/250px-Mikael_H%C3%A4ggstr%C3%B6m_at_pathology_in_2019_%28crop%29.jpg\" decoding=\"async\" width=\"135\" height=\"159\" class=\"mw-file-element\" srcset=\"https://upload.wikimedia.org/wikipedia/commons/thumb/f/f1/Mikael_H%C3%A4ggstr%C3%B6m_at_pathology_in_2019_%28crop%29.jpg/330px-Mikael_H%C3%A4ggstr%C3%B6m_at_pathology_in_2019_%28crop%29.jpg 2x\" data-file-width=\"1439\" data-file-height=\"1697\"></a><figcaption><a href=\"//commons.wikimedia.org/wiki/User:Mikael_H%C3%A4ggstr%C3%B6m\" title=\"User:Mikael H√§ggstr√∂m\">Mikael H√§ggstr√∂m</a>, <a href=\"https://en.wikipedia.org/wiki/Medical_Doctor\" class=\"extiw\" title=\"en:Medical Doctor\">M.D.</a> <a href=\"//commons.wikimedia.org/wiki/Mikael_H%C3%A4ggstr%C3%B6m\" class=\"mw-redirect\" title=\"Mikael H√§ggstr√∂m\">Author info</a><br> - <a href=\"//commons.wikimedia.org/wiki/User:Mikael_H%C3%A4ggstr%C3%B6m#Reusing_images\" title=\"User:Mikael H√§ggstr√∂m\">Reusing images</a><br>- Conflicts of interest:<br>¬† None</figcaption></figure>\n<a href=\"//commons.wikimedia.org/wiki/User:Mikael_H%C3%A4ggstr%C3%B6m\" title=\"User:Mikael H√§ggstr√∂m\">Mikael H√§ggstr√∂m</a>, <a href=\"https://en.wikipedia.org/wiki/Medical_Doctor\" class=\"extiw\" title=\"en:Medical Doctor\">M.D.</a><br><b>Consent note</b>: Consent from the patient or patient's relatives is regarded as redundant, because of absence of identifiable features (<a rel=\"nofollow\" class=\"external text\" href=\"https://research.ucr.edu/ori/committees/irb-clin/hipaa/hipaa-phi-identifiers\">List of HIPAA identifiers</a>) in the media and case information (<a rel=\"nofollow\" class=\"external text\" href=\"https://research.ucr.edu/media/34266/hipaa_case_reports.pdf\">See also HIPAA case reports guidance</a>).",
          "description": "Histopathology of amyloid plaque in the <a href=\"https://en.wikipedia.org/wiki/hippocampus\" class=\"extiw\" title=\"en:hippocampus\">hippocampus</a> in <a href=\"https://en.wikipedia.org/wiki/Alzheimer%27s_disease\" class=\"extiw\" title=\"en:Alzheimer's disease\">Alzheimer's disease</a>. H&amp;E stain.",
          "credit": "<span class=\"int-own-work\" lang=\"en\">Own work</span>",
          "license": "cc0",
          "url": "https://commons.wikimedia.org/wiki/File:Histopathology_of_amyloid_plaque_in_Alzheimer's_disease_-_annotated.jpg"
        },
        {
          "title": "File:Histopathology of amyloid plaque in Alzheimer's disease.jpg",
          "author": "<figure typeof=\"mw:File/Thumb\"><a href=\"//commons.wikimedia.org/wiki/File:Mikael_H%C3%A4ggstr%C3%B6m_at_pathology_in_2019_(crop).jpg\" class=\"mw-file-description\"><img src=\"https://upload.wikimedia.org/wikipedia/commons/thumb/f/f1/Mikael_H%C3%A4ggstr%C3%B6m_at_pathology_in_2019_%28crop%29.jpg/250px-Mikael_H%C3%A4ggstr%C3%B6m_at_pathology_in_2019_%28crop%29.jpg\" decoding=\"async\" width=\"135\" height=\"159\" class=\"mw-file-element\" srcset=\"https://upload.wikimedia.org/wikipedia/commons/thumb/f/f1/Mikael_H%C3%A4ggstr%C3%B6m_at_pathology_in_2019_%28crop%29.jpg/330px-Mikael_H%C3%A4ggstr%C3%B6m_at_pathology_in_2019_%28crop%29.jpg 2x\" data-file-width=\"1439\" data-file-height=\"1697\"></a><figcaption><a href=\"//commons.wikimedia.org/wiki/User:Mikael_H%C3%A4ggstr%C3%B6m\" title=\"User:Mikael H√§ggstr√∂m\">Mikael H√§ggstr√∂m</a>, <a href=\"https://en.wikipedia.org/wiki/Medical_Doctor\" class=\"extiw\" title=\"en:Medical Doctor\">M.D.</a> <a href=\"//commons.wikimedia.org/wiki/Mikael_H%C3%A4ggstr%C3%B6m\" class=\"mw-redirect\" title=\"Mikael H√§ggstr√∂m\">Author info</a><br> - <a href=\"//commons.wikimedia.org/wiki/User:Mikael_H%C3%A4ggstr%C3%B6m#Reusing_images\" title=\"User:Mikael H√§ggstr√∂m\">Reusing images</a><br>- Conflicts of interest:<br>¬† None</figcaption></figure>\n<a href=\"//commons.wikimedia.org/wiki/User:Mikael_H%C3%A4ggstr%C3%B6m\" title=\"User:Mikael H√§ggstr√∂m\">Mikael H√§ggstr√∂m</a>, <a href=\"https://en.wikipedia.org/wiki/Medical_Doctor\" class=\"extiw\" title=\"en:Medical Doctor\">M.D.</a><br><b>Consent note</b>: Consent from the patient or patient's relatives is regarded as redundant, because of absence of identifiable features (<a rel=\"nofollow\" class=\"external text\" href=\"https://research.ucr.edu/ori/committees/irb-clin/hipaa/hipaa-phi-identifiers\">List of HIPAA identifiers</a>) in the media and case information (<a rel=\"nofollow\" class=\"external text\" href=\"https://research.ucr.edu/media/34266/hipaa_case_reports.pdf\">See also HIPAA case reports guidance</a>).",
          "description": "Histopathology of amyloid plaque in the <a href=\"https://en.wikipedia.org/wiki/hippocampus\" class=\"extiw\" title=\"en:hippocampus\">hippocampus</a> in <a href=\"https://en.wikipedia.org/wiki/Alzheimer%27s_disease\" class=\"extiw\" title=\"en:Alzheimer's disease\">Alzheimer's disease</a>. H&amp;E stain.",
          "credit": "<span class=\"int-own-work\" lang=\"en\">Own work</span>",
          "license": "cc0",
          "url": "https://commons.wikimedia.org/wiki/File:Histopathology_of_amyloid_plaque_in_Alzheimer's_disease.jpg"
        },
        {
          "title": "File:Histopathology of neurofibrillary tangles in Alzheimer's disease.jpg",
          "author": "<figure typeof=\"mw:File/Thumb\"><a href=\"//commons.wikimedia.org/wiki/File:Mikael_H%C3%A4ggstr%C3%B6m_at_pathology_in_2019_(crop).jpg\" class=\"mw-file-description\"><img src=\"https://upload.wikimedia.org/wikipedia/commons/thumb/f/f1/Mikael_H%C3%A4ggstr%C3%B6m_at_pathology_in_2019_%28crop%29.jpg/250px-Mikael_H%C3%A4ggstr%C3%B6m_at_pathology_in_2019_%28crop%29.jpg\" decoding=\"async\" width=\"135\" height=\"159\" class=\"mw-file-element\" srcset=\"https://upload.wikimedia.org/wikipedia/commons/thumb/f/f1/Mikael_H%C3%A4ggstr%C3%B6m_at_pathology_in_2019_%28crop%29.jpg/330px-Mikael_H%C3%A4ggstr%C3%B6m_at_pathology_in_2019_%28crop%29.jpg 2x\" data-file-width=\"1439\" data-file-height=\"1697\"></a><figcaption><a href=\"//commons.wikimedia.org/wiki/User:Mikael_H%C3%A4ggstr%C3%B6m\" title=\"User:Mikael H√§ggstr√∂m\">Mikael H√§ggstr√∂m</a>, <a href=\"https://en.wikipedia.org/wiki/Medical_Doctor\" class=\"extiw\" title=\"en:Medical Doctor\">M.D.</a> <a href=\"//commons.wikimedia.org/wiki/Mikael_H%C3%A4ggstr%C3%B6m\" class=\"mw-redirect\" title=\"Mikael H√§ggstr√∂m\">Author info</a><br> - <a href=\"//commons.wikimedia.org/wiki/User:Mikael_H%C3%A4ggstr%C3%B6m#Reusing_images\" title=\"User:Mikael H√§ggstr√∂m\">Reusing images</a><br>- Conflicts of interest:<br>¬† None</figcaption></figure>\n<a href=\"//commons.wikimedia.org/wiki/User:Mikael_H%C3%A4ggstr%C3%B6m\" title=\"User:Mikael H√§ggstr√∂m\">Mikael H√§ggstr√∂m</a>, <a href=\"https://en.wikipedia.org/wiki/Medical_Doctor\" class=\"extiw\" title=\"en:Medical Doctor\">M.D.</a><br><b>Consent note</b>: Consent from the patient or patient's relatives is regarded as redundant, because of absence of identifiable features (<a rel=\"nofollow\" class=\"external text\" href=\"https://research.ucr.edu/ori/committees/irb-clin/hipaa/hipaa-phi-identifiers\">List of HIPAA identifiers</a>) in the media and case information (<a rel=\"nofollow\" class=\"external text\" href=\"https://research.ucr.edu/media/34266/hipaa_case_reports.pdf\">See also HIPAA case reports guidance</a>).",
          "description": "Histopathology of neurofibrillary tangles in the <a href=\"https://en.wikipedia.org/wiki/hippocampus\" class=\"extiw\" title=\"en:hippocampus\">hippocampus</a> in <a href=\"https://en.wikipedia.org/wiki/Alzheimer%27s_disease\" class=\"extiw\" title=\"en:Alzheimer's disease\">Alzheimer's disease</a>. H&amp;E stain.",
          "credit": "<span class=\"int-own-work\" lang=\"en\">Own work</span>",
          "license": "cc0",
          "url": "https://commons.wikimedia.org/wiki/File:Histopathology_of_neurofibrillary_tangles_in_Alzheimer's_disease.jpg"
        },
        {
          "title": "File:Histopathology of granulovacuolar degeneration in Alzheimer's disease.jpg",
          "author": "<figure typeof=\"mw:File/Thumb\"><a href=\"//commons.wikimedia.org/wiki/File:Mikael_H%C3%A4ggstr%C3%B6m_at_pathology_in_2019_(crop).jpg\" class=\"mw-file-description\"><img src=\"https://upload.wikimedia.org/wikipedia/commons/thumb/f/f1/Mikael_H%C3%A4ggstr%C3%B6m_at_pathology_in_2019_%28crop%29.jpg/250px-Mikael_H%C3%A4ggstr%C3%B6m_at_pathology_in_2019_%28crop%29.jpg\" decoding=\"async\" width=\"135\" height=\"159\" class=\"mw-file-element\" srcset=\"https://upload.wikimedia.org/wikipedia/commons/thumb/f/f1/Mikael_H%C3%A4ggstr%C3%B6m_at_pathology_in_2019_%28crop%29.jpg/330px-Mikael_H%C3%A4ggstr%C3%B6m_at_pathology_in_2019_%28crop%29.jpg 2x\" data-file-width=\"1439\" data-file-height=\"1697\"></a><figcaption><a href=\"//commons.wikimedia.org/wiki/User:Mikael_H%C3%A4ggstr%C3%B6m\" title=\"User:Mikael H√§ggstr√∂m\">Mikael H√§ggstr√∂m</a>, <a href=\"https://en.wikipedia.org/wiki/Medical_Doctor\" class=\"extiw\" title=\"en:Medical Doctor\">M.D.</a> <a href=\"//commons.wikimedia.org/wiki/Mikael_H%C3%A4ggstr%C3%B6m\" class=\"mw-redirect\" title=\"Mikael H√§ggstr√∂m\">Author info</a><br> - <a href=\"//commons.wikimedia.org/wiki/User:Mikael_H%C3%A4ggstr%C3%B6m#Reusing_images\" title=\"User:Mikael H√§ggstr√∂m\">Reusing images</a><br>- Conflicts of interest:<br>¬† None</figcaption></figure>\n<a href=\"//commons.wikimedia.org/wiki/User:Mikael_H%C3%A4ggstr%C3%B6m\" title=\"User:Mikael H√§ggstr√∂m\">Mikael H√§ggstr√∂m</a>, <a href=\"https://en.wikipedia.org/wiki/Medical_Doctor\" class=\"extiw\" title=\"en:Medical Doctor\">M.D.</a><br><b>Consent note</b>: Consent from the patient or patient's relatives is regarded as redundant, because of absence of identifiable features (<a rel=\"nofollow\" class=\"external text\" href=\"https://research.ucr.edu/ori/committees/irb-clin/hipaa/hipaa-phi-identifiers\">List of HIPAA identifiers</a>) in the media and case information (<a rel=\"nofollow\" class=\"external text\" href=\"https://research.ucr.edu/media/34266/hipaa_case_reports.pdf\">See also HIPAA case reports guidance</a>).",
          "description": "Histopathology of granulovacuolar degeneration in the <a href=\"https://en.wikipedia.org/wiki/hippocampus\" class=\"extiw\" title=\"en:hippocampus\">hippocampus</a> in <a href=\"https://en.wikipedia.org/wiki/Alzheimer%27s_disease\" class=\"extiw\" title=\"en:Alzheimer's disease\">Alzheimer's disease</a>. H&amp;E stain.",
          "credit": "<span class=\"int-own-work\" lang=\"en\">Own work</span>",
          "license": "cc0",
          "url": "https://commons.wikimedia.org/wiki/File:Histopathology_of_granulovacuolar_degeneration_in_Alzheimer's_disease.jpg"
        },
        {
          "title": "File:Alzheimer's disease brain severe.jpg",
          "author": "ADEAR:  \"Alzheimer's Disease Education and Referral Center, a service of the National Institute on Aging.\"",
          "description": "Diagram of the brain of a person with Alzheimer's Disease",
          "credit": "<a rel=\"nofollow\" class=\"external free\" href=\"http://www.nia.nih.gov/Alzheimers/Resources/HighRes.htm\">http://www.nia.nih.gov/Alzheimers/Resources/HighRes.htm</a>",
          "license": "pd",
          "url": "https://commons.wikimedia.org/wiki/File:Alzheimer's_disease_brain_severe.jpg"
        },
        {
          "title": "File:Alzheimer's disease brain preclinical.jpg",
          "author": "ADEAR:  \"Alzheimer's Disease Education and Referral Center, a service of the National Institute on Aging.\"",
          "description": "Diagram of a normal brain",
          "credit": "<a rel=\"nofollow\" class=\"external free\" href=\"http://www.nia.nih.gov/Alzheimers/Resources/HighRes.htm\">http://www.nia.nih.gov/Alzheimers/Resources/HighRes.htm</a>",
          "license": "pd",
          "url": "https://commons.wikimedia.org/wiki/File:Alzheimer's_disease_brain_preclinical.jpg"
        }
      ],
      [
        {
          "title": "File:Step-by-step guide for analyzing microglia phenotypes.png",
          "author": "Schwabenland, M., Br√ºck, W., Priller, J. et al. Analyzing microglial phenotypes across neuropathologies: a practical guide. Acta Neuropathol 142, 923‚Äì936 (2021). <a rel=\"nofollow\" class=\"external free\" href=\"https://doi.org/10.1007/s00401-021-02370-8\">https://doi.org/10.1007/s00401-021-02370-8</a>",
          "description": "The image depicts a stepwise guide for analyzing microglia using Iba1 immunohistochemistry in histology, proposed in Schwabenland, M., Br√ºck, W., Priller, J. et al. Analyzing microglial phenotypes across neuropathologies: a practical guide. Acta Neuropathol 142, 923‚Äì936 (2021). <a rel=\"nofollow\" class=\"external free\" href=\"https://doi.org/10.1007/s00401-021-02370-8\">https://doi.org/10.1007/s00401-021-02370-8</a>",
          "credit": "<p>Schwabenland, M., Br√ºck, W., Priller, J. et al. Analyzing microglial phenotypes across neuropathologies: a practical guide. Acta Neuropathol 142, 923‚Äì936 (2021). <a rel=\"nofollow\" class=\"external free\" href=\"https://doi.org/10.1007/s00401-021-02370-8\">https://doi.org/10.1007/s00401-021-02370-8</a>\n</p>\nThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit <a rel=\"nofollow\" class=\"external free\" href=\"https://creativecommons.org/licenses/by/4.0/\">https://creativecommons.org/licenses/by/4.0/</a>.",
          "license": "cc-by-4.0",
          "url": "https://commons.wikimedia.org/wiki/File:Step-by-step_guide_for_analyzing_microglia_phenotypes.png"
        },
        {
          "title": "File:Neuroinflammation-induced changes in microglia that are implicated in SCZ pathogenicity.jpg",
          "author": "Comer AL, Carrier M, Tremblay M√à, Cruz-Mart√≠n A. The Inflamed Brain in Schizophrenia: The Convergence of Genetic and Environmental Risk Factors That Lead to Uncontrolled Neuroinflammation. Front Cell Neurosci. 2020 Aug 27;14:274. doi: 10.3389/fncel.2020.00274. PMID: 33061891; PMCID: PMC7518314.",
          "description": "Neuroinflammation-induced changes in microglia that are implicated in SCZ pathogenicity. \n<p>Risk factors for SCZ that alter microglial function and enhance neuroinflammation include pollution, stress, nutrition induced gut-brain axis dysbiosis, viral infection, maternal immune activation, genetic predisposition, and cytokine secretion.\n</p>\nHomeostatic microglia perform their immune sentinel role by interacting with neurons to guide circuit wiring during development. In an increased inflammatory milieu, loss of microglial homeostasis perturbs microglia-neuron interactions that may cause altered plasticity due to pathogenic synaptic formation, synaptic stripping, and pruning. Therapeutic approaches that promote homeostatic microglia through the reduction of neuroinflammation via anti-inflammatory drugs, microglial inhibition and repopulation, improved nutrition, environmental enrichment, and prevention of psychological stress could be potentially exploited to limit exacerbation of SCZ.",
          "credit": "<a rel=\"nofollow\" class=\"external free\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33061891/\">https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33061891/</a>",
          "license": "cc-by-4.0",
          "url": "https://commons.wikimedia.org/wiki/File:Neuroinflammation-induced_changes_in_microglia_that_are_implicated_in_SCZ_pathogenicity.jpg"
        },
        {
          "title": "File:The Glowing Emptiness of an Alzheimer's Disease Patient.jpg",
          "author": "<a href=\"//commons.wikimedia.org/w/index.php?title=User:Nicocapelo&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"User:Nicocapelo (page does not exist)\">Nicocapelo</a>",
          "description": "How can an explosion of colour be so damaging? How can so much light turn into absolute darkness? This is the sad reality that floods the brains of our Alzheimer's patients. The massive accumulation of these beta-amyloid plaques is one of the main causes of this pathology. It seems paradoxical to think that something so beautiful, observed through the lens of a confocal microscope, can result in the greatest harm to dementia sufferers. But perhaps that glow does symbolise something else, because wherever a plaque is located, microglia and astrocytes will fight side by side to prevent its spread and extension, giving a glimmer of hope to those who fight against neurodegeneration day after day.\nImage taken with reflection confocal and/or scanning spectral fluorescence microscope LEICA Stellaris 8. Objective: HCX PL APO 63x/1.30 Glyc W.D. 0.30 mm. Composite made from 43 Z-planes with LASX 3D software and post-processed with FIJI.",
          "credit": "<span class=\"int-own-work\" lang=\"en\">Own work</span>",
          "license": "cc-by-sa-4.0",
          "url": "https://commons.wikimedia.org/wiki/File:The_Glowing_Emptiness_of_an_Alzheimer's_Disease_Patient.jpg"
        },
        {
          "title": "File:The Tiny, Circumspect Rival of the Central Nervous System.jpg",
          "author": "<a href=\"//commons.wikimedia.org/w/index.php?title=User:Nicocapelo&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"User:Nicocapelo (page does not exist)\">Nicocapelo</a>",
          "description": "Slight forgetfulness, typically categorised as absurd. Out-of-place answers, classically blamed on age. Perhaps this is familiar to you, as this is the reality of countless elderly people in our society. Alzheimer's disease, silent and cautious, wears down the brains of those who suffer from it. These carelessnesses are no longer sporadic, absences, bad manners or lack of initiative appear, and can even end in total disability. Is it not complex to think that one of its causes is the accumulation of an element even smaller than the COVID-19 virus? This image shows microglia and astrocytes, components of our brain's immune system, in the heat of battle against those beta-amyloid protein plaques, the drivers of the concatenation of events presented above. Being able to study them at this level of detail will allow us to better understand the pathology and, hopefully in the near future, to develop effective therapies against the origin of the disease.",
          "credit": "<span class=\"int-own-work\" lang=\"en\">Own work</span>",
          "license": "cc-by-sa-4.0",
          "url": "https://commons.wikimedia.org/wiki/File:The_Tiny,_Circumspect_Rival_of_the_Central_Nervous_System.jpg"
        },
        {
          "title": "File:Beyond Pathway Analysis Identification of Active Subnetworks in Rett Syndrome (fig 3).jpg",
          "author": "Ryan A Miller 1, Friederike Ehrhart 1 2, Lars M T Eijssen 1 3, Denise N Slenter 1, Leopold M G Curfs 2, Chris T Evelo 1 2 4, Egon L Willighagen 1, Martina Kutmon 1 4",
          "description": "Visualization of the frontal and temporal cortex gene expression on the Microglia Pathway Phagocytosis Pathway. In the left half of the gene boxes, the gene expression change in the frontal cortex is shown. In the right half of the gene boxes, the gene expression in the temporal cortex is shown. The blue colors represent down-regulation of the gene in Rett syndrome patients (negative log2 fold change), while the red shades visualize the up-regulated genes. The darker the color, the stronger the effect. Green borders indicate significance of the change (p-value &lt; 0.05). Gray colored nodes are not annotated or measured in the dataset.",
          "credit": "<a rel=\"nofollow\" class=\"external free\" href=\"https://pubmed.ncbi.nlm.nih.gov/30847002/\">https://pubmed.ncbi.nlm.nih.gov/30847002/</a>",
          "license": "cc-by-4.0",
          "url": "https://commons.wikimedia.org/wiki/File:Beyond_Pathway_Analysis_Identification_of_Active_Subnetworks_in_Rett_Syndrome_(fig_3).jpg"
        }
      ],
      [
        {
          "title": "File:Amyloid-beta-42 1IYT.png",
          "author": "own work",
          "description": "stick/ribbon model of AŒ≤42 after PDB 1IYT. Ref.: <cite style=\"font-style:normal\">Crescenzi O, Tomaselli S, Guerrini R, <i>et al</i> (November 2002). \"<a rel=\"nofollow\" class=\"external text\" href=\"http://www3.interscience.wiley.com/resolve/openurl?genre=article&amp;sid=nlm:pubmed&amp;issn=0014-2956&amp;date=2002&amp;volume=269&amp;issue=22&amp;spage=5642\">Solution structure of the Alzheimer amyloid beta-peptide (1-42) in an apolar microenvironment. Similarity with a virus fusion domain</a>\". <i>Eur. J. Biochem.</i> <b>269</b> (22): 5642‚Äì8. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/PubMed\" class=\"extiw\" title=\"en:PubMed\"><span lang=\"en\" dir=\"ltr\">PMID</span></a></span> <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pubmed/12423364\">12423364</a>.</cite><sup class=\"noprint Inline-Template\"><span style=\"white-space: nowrap;\">[<span style=\"font-style:italic;\"><span title=\" since May 2021\" class=\"plainlinks\"><a class=\"external text\" href=\"https://en.wikipedia.org/wiki/Wikipedia:Link_rot\">dead link</a></span></span>]</span></sup>",
          "credit": "adapted from <a rel=\"nofollow\" class=\"external free\" href=\"http://www.pdb.org/pdb/cgi/explore.cgi?pdbId=1IYT\">http://www.pdb.org/pdb/cgi/explore.cgi?pdbId=1IYT</a> using PyMOL",
          "license": "pd",
          "url": "https://commons.wikimedia.org/wiki/File:Amyloid-beta-42_1IYT.png"
        },
        {
          "title": "File:Amyloid-plaque formation-big.jpg",
          "author": "<ul><li>derivative work: <a href=\"//commons.wikimedia.org/wiki/User:Garrondo\" title=\"User:Garrondo\">Garrondo</a> (<a href=\"//commons.wikimedia.org/wiki/User_talk:Garrondo\" title=\"User talk:Garrondo\">talk</a>)</li>\n<li><a href=\"//commons.wikimedia.org/wiki/File:Amyloid_01big1.jpg\" title=\"File:Amyloid 01big1.jpg\">Amyloid_01big1.jpg</a>: ADEAR: \"Alzheimer's Disease Education and Referral Center, a service of the National Institute on Aging.\"</li></ul>",
          "description": "Enzymes act on the APP (Amyloid precursor protein) and cut it into fragments of protein, one of which is called beta-amyloid and its crucial in the formation of senile plaques in Alzheimer",
          "credit": "<ul><li><a href=\"//commons.wikimedia.org/wiki/File:Amyloid_01big1.jpg\" title=\"File:Amyloid 01big1.jpg\">Amyloid_01big1.jpg</a></li>\n<li><a href=\"//commons.wikimedia.org/wiki/File:Amyloid_02big1.jpg\" title=\"File:Amyloid 02big1.jpg\">Amyloid_02big1.jpg</a></li>\n<li><a href=\"//commons.wikimedia.org/wiki/File:Amyloid_03big1.jpg\" title=\"File:Amyloid 03big1.jpg\">Amyloid_03big1.jpg</a></li></ul>",
          "license": "pd",
          "url": "https://commons.wikimedia.org/wiki/File:Amyloid-plaque_formation-big.jpg"
        },
        {
          "title": "File:Amyloid-plaque formation-spa.jpg",
          "author": "<ul><li>derivative work: <a href=\"//commons.wikimedia.org/wiki/User:Garrondo\" title=\"User:Garrondo\">Garrondo</a> (<a href=\"//commons.wikimedia.org/wiki/User_talk:Garrondo\" title=\"User talk:Garrondo\">talk</a>)</li>\n<li><a href=\"//commons.wikimedia.org/wiki/File:Amyloid_01big1.jpg\" title=\"File:Amyloid 01big1.jpg\">Amyloid_01big1.jpg</a>: ADEAR: \"Alzheimer's Disease Education and Referral Center, a service of the National Institute on Aging.\"</li></ul>",
          "description": "Diversas enzimas act√∫an sobre la Prote√≠na Precursora de Amiloides (APP) y la cortan en fragmentos, uno de los cuales es el beta-amiloide el cual es indispensable para la formaci√≥n de placas seniles caracter√≠stica de la enfermedad de Alzheimer.",
          "credit": "Translation of <a href=\"//commons.wikimedia.org/wiki/File:Amyloid-plaque_formation-big.jpg\" title=\"File:Amyloid-plaque formation-big.jpg\">existing image.</a>",
          "license": "pd",
          "url": "https://commons.wikimedia.org/wiki/File:Amyloid-plaque_formation-spa.jpg"
        },
        {
          "title": "File:PDB 1rw6 EBI.jpg",
          "author": "Jawahar Swaminathan and MSD staff at the <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/European_Bioinformatics_Institute\" class=\"extiw\" title=\"en:European Bioinformatics Institute\"><span lang=\"en\" dir=\"ltr\">European Bioinformatics Institute</span></a></span>",
          "description": "Cartoon representation of the molecular structure of protein registered with 1rw6 code.",
          "credit": "<a rel=\"nofollow\" class=\"external free\" href=\"https://www.ebi.ac.uk/pdbe/static/entry/1rw6_deposited_chain_front_image-800x800.png\">https://www.ebi.ac.uk/pdbe/static/entry/1rw6_deposited_chain_front_image-800x800.png</a>, displayed on <a rel=\"nofollow\" class=\"external free\" href=\"https://www.ebi.ac.uk/pdbe/entry/pdb/1rw6\">https://www.ebi.ac.uk/pdbe/entry/pdb/1rw6</a>",
          "license": "pd",
          "url": "https://commons.wikimedia.org/wiki/File:PDB_1rw6_EBI.jpg"
        },
        {
          "title": "File:PDB 1amc EBI.jpg",
          "author": "Jawahar Swaminathan and MSD staff at the <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/European_Bioinformatics_Institute\" class=\"extiw\" title=\"en:European Bioinformatics Institute\"><span lang=\"en\" dir=\"ltr\">European Bioinformatics Institute</span></a></span>",
          "description": "Cartoon representation of the molecular structure of protein registered with 1amc code.",
          "credit": "<a rel=\"nofollow\" class=\"external free\" href=\"https://www.ebi.ac.uk/pdbe/static/entry/1amc_deposited_chain_front_image-800x800.png\">https://www.ebi.ac.uk/pdbe/static/entry/1amc_deposited_chain_front_image-800x800.png</a>, displayed on <a rel=\"nofollow\" class=\"external free\" href=\"https://www.ebi.ac.uk/pdbe/entry/pdb/1amc\">https://www.ebi.ac.uk/pdbe/entry/pdb/1amc</a>",
          "license": "pd",
          "url": "https://commons.wikimedia.org/wiki/File:PDB_1amc_EBI.jpg"
        },
        {
          "title": "File:PDB 1aml EBI.jpg",
          "author": "Jawahar Swaminathan and MSD staff at the <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/European_Bioinformatics_Institute\" class=\"extiw\" title=\"en:European Bioinformatics Institute\"><span lang=\"en\" dir=\"ltr\">European Bioinformatics Institute</span></a></span>",
          "description": "Cartoon representation of the molecular structure of protein registered with 1aml code.",
          "credit": "<a rel=\"nofollow\" class=\"external free\" href=\"https://www.ebi.ac.uk/pdbe/static/entry/1aml_deposited_chain_front_image-800x800.png\">https://www.ebi.ac.uk/pdbe/static/entry/1aml_deposited_chain_front_image-800x800.png</a>, displayed on <a rel=\"nofollow\" class=\"external free\" href=\"https://www.ebi.ac.uk/pdbe/entry/pdb/1aml\">https://www.ebi.ac.uk/pdbe/entry/pdb/1aml</a>",
          "license": "pd",
          "url": "https://commons.wikimedia.org/wiki/File:PDB_1aml_EBI.jpg"
        },
        {
          "title": "File:PDB 1tkn EBI.jpg",
          "author": "Jawahar Swaminathan and MSD staff at the <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/European_Bioinformatics_Institute\" class=\"extiw\" title=\"en:European Bioinformatics Institute\"><span lang=\"en\" dir=\"ltr\">European Bioinformatics Institute</span></a></span>",
          "description": "Cartoon representation of the molecular structure of protein registered with 1tkn code.",
          "credit": "<a rel=\"nofollow\" class=\"external free\" href=\"https://www.ebi.ac.uk/pdbe/static/entry/1tkn_deposited_chain_front_image-800x800.png\">https://www.ebi.ac.uk/pdbe/static/entry/1tkn_deposited_chain_front_image-800x800.png</a>, displayed on <a rel=\"nofollow\" class=\"external free\" href=\"https://www.ebi.ac.uk/pdbe/entry/pdb/1tkn\">https://www.ebi.ac.uk/pdbe/entry/pdb/1tkn</a>",
          "license": "pd",
          "url": "https://commons.wikimedia.org/wiki/File:PDB_1tkn_EBI.jpg"
        },
        {
          "title": "File:Protofilament of Beta Amyloid.jpg",
          "author": "<a href=\"//commons.wikimedia.org/w/index.php?title=User:Pierre_Hugots&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"User:Pierre Hugots (page does not exist)\">Pierre Hugots</a>",
          "description": "Structural Model for a 40-residue Beta-Amyloid Protofilament with Three-Fold Symmetry, Negative Stagger (PDB 2MLQ)",
          "credit": "<span class=\"int-own-work\" lang=\"en\">Own work</span>",
          "license": "cc-by-sa-4.0",
          "url": "https://commons.wikimedia.org/wiki/File:Protofilament_of_Beta_Amyloid.jpg"
        },
        {
          "title": "File:PDB 1qxc EBI.jpg",
          "author": "Jawahar Swaminathan and MSD staff at the <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/European_Bioinformatics_Institute\" class=\"extiw\" title=\"en:European Bioinformatics Institute\"><span lang=\"en\" dir=\"ltr\">European Bioinformatics Institute</span></a></span>",
          "description": "Cartoon representation of the molecular structure of protein registered with 1qxc code.",
          "credit": "<a rel=\"nofollow\" class=\"external free\" href=\"https://www.ebi.ac.uk/pdbe/static/entry/1qxc_deposited_chain_front_image-800x800.png\">https://www.ebi.ac.uk/pdbe/static/entry/1qxc_deposited_chain_front_image-800x800.png</a>, displayed on <a rel=\"nofollow\" class=\"external free\" href=\"https://www.ebi.ac.uk/pdbe/entry/pdb/1qxc\">https://www.ebi.ac.uk/pdbe/entry/pdb/1qxc</a>",
          "license": "pd",
          "url": "https://commons.wikimedia.org/wiki/File:PDB_1qxc_EBI.jpg"
        },
        {
          "title": "File:PDB 1qwp EBI.jpg",
          "author": "Jawahar Swaminathan and MSD staff at the <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/European_Bioinformatics_Institute\" class=\"extiw\" title=\"en:European Bioinformatics Institute\"><span lang=\"en\" dir=\"ltr\">European Bioinformatics Institute</span></a></span>",
          "description": "Cartoon representation of the molecular structure of protein registered with 1qwp code.",
          "credit": "<a rel=\"nofollow\" class=\"external free\" href=\"https://www.ebi.ac.uk/pdbe/static/entry/1qwp_deposited_chain_front_image-800x800.png\">https://www.ebi.ac.uk/pdbe/static/entry/1qwp_deposited_chain_front_image-800x800.png</a>, displayed on <a rel=\"nofollow\" class=\"external free\" href=\"https://www.ebi.ac.uk/pdbe/entry/pdb/1qwp\">https://www.ebi.ac.uk/pdbe/entry/pdb/1qwp</a>",
          "license": "pd",
          "url": "https://commons.wikimedia.org/wiki/File:PDB_1qwp_EBI.jpg"
        }
      ]
    ]
  },
  {
    "title": "Transmembrane protein interacts with Œ±-synuclein to confer risk of PD",
    "authors": [
      "Lempri√®re, Sarah"
    ],
    "abstract": [
      ""
    ],
    "url": "https://doi.org/10.1038/s41582-022-00716-8",
    "journal": "Nature Reviews Neurology",
    "keywords": [
      "Parkinson's disease",
      "Œ±-synuclein",
      "biomarker"
    ],
    "caption": "üî¨ Exciting new research highlights the role of Transmembrane glycoprotein NMB (GPNMB) in Parkinson's disease (PD) risk through its interaction with Œ±-synuclein. This discovery positions GPNMB as a potential biomarker and therapeutic target for PD, opening new avenues for early detection and treatment strategies. üß†‚ú® As we continue to unravel the complexities of neurodegenerative diseases, findings like these are crucial in our fight against PD. \n\n#Neuroscience #ParkinsonsDisease #Research #Innovation #ScienceNews",
    "images": [
      [
        {
          "title": "File:Parkinson's disease pathway (Homo sapiens).png",
          "author": "Alexander Pico, Kristina Hanspers, Egon Willighagen, Friederike Ehrhart, Eric Weitz, Martina Kutmon",
          "description": "Most people with Parkinson's disease have idiopathic Parkinson's disease (having no specific known cause). A small proportion of cases, however, can be attributed to known genetic factors. Mutations in specific genes have been conclusively shown to cause PD. These genes code for alpha-synuclein (SNCA), parkin (PRKN), leucine-rich repeat kinase 2 (LRRK2 or dardarin), PTEN-induced putative kinase 1 (PINK1), DJ-1 and ATP13A2.[4][22] In most cases, people with these mutations will develop PD. With the exception of LRRK2, however, they account for only a small minority of cases of PD.[4] The most extensively studied PD-related genes are SNCA and LRRK2. Mutations in genes including SNCA, LRRK2 and glucocerebrosidase (GBA) have been found to be risk factors for sporadic PD. The role of the SNCA gene is important in PD because the alpha-synuclein protein is the main component of Lewy bodies.[22] Missense mutations of the gene (in which a single nucleotide is changed), and duplications and triplications of the locus containing it have been found in different groups with familial PD. Mutations in LRRK2 are the most common known cause of familial and sporadic PD, accounting for approximately 5% of individuals with a family history of the disease and 3% of sporadic cases.",
          "credit": "<a rel=\"nofollow\" class=\"external free\" href=\"https://www.wikipathways.org/instance/WP2371\">https://www.wikipathways.org/instance/WP2371</a>",
          "license": "cc0",
          "url": "https://commons.wikimedia.org/wiki/File:Parkinson's_disease_pathway_(Homo_sapiens).png"
        },
        {
          "title": "File:Parkinson‚Äôs disease 1880s.jpg",
          "author": "William Gowers; retouched by <a href=\"//commons.wikimedia.org/wiki/User:Dustfreeworld\" title=\"User:Dustfreeworld\">User:Dustfreeworld</a>",
          "description": "Person with Parkinson‚Äôs disease. A retouched image from the drawings of a William Gowers. Color, brightness and size adjusted.\n<p><a class=\"external free\" href=\"https://commons.wikimedia.org/wiki/File:Drawings_of_a_Parkinson_patient_by_William_Gowers.jpg\">https://commons.wikimedia.org/wiki/File:Drawings_of_a_Parkinson_patient_by_William_Gowers.jpg</a>\n</p>\n<a rel=\"nofollow\" class=\"external free\" href=\"https://movementdisorders.onlinelibrary.wiley.com/doi/full/10.1002/mds.27965\">https://movementdisorders.onlinelibrary.wiley.com/doi/full/10.1002/mds.27965</a>",
          "credit": "<a href=\"//commons.wikimedia.org/wiki/File:Person_with_Parkinson_disease_BW.jpg\" title=\"File:Person with Parkinson disease BW.jpg\">File:Person_with_Parkinson_disease_BW.jpg</a>",
          "license": "pd",
          "url": "https://commons.wikimedia.org/wiki/File:Parkinson‚Äôs_disease_1880s.jpg"
        },
        {
          "title": "File:Basal ganglia without Parkinson's disease.png",
          "author": "<a href=\"//commons.wikimedia.org/wiki/User:Mikael_H%C3%A4ggstr%C3%B6m\" title=\"User:Mikael H√§ggstr√∂m\">Mikael H√§ggstr√∂m</a>, based on images by Andrew Gillies/User:Anaru and Patrick J. Lynch",
          "description": "Main circuits of the <a href=\"https://en.wikipedia.org/wiki/basal_ganglia\" class=\"extiw\" title=\"en:basal ganglia\">basal ganglia</a>, derived from <a href=\"//commons.wikimedia.org/wiki/File:Basal_ganglia_circuits.svg\" title=\"File:Basal ganglia circuits.svg\">Basal ganglia circuits.svg</a> without pars reticularis pathways for simplification. Picture shows 2 coronal slices that have been superimposed to include the involved basal ganglia structures. + and - signs at the point of the arrows indicate respectively whether the pathway is excitatory or inhibitory in effect. <font color=\"green\">Green arrows</font> refer to excitatory <a href=\"https://en.wikipedia.org/wiki/Glutamic_acid\" class=\"extiw\" title=\"en:Glutamic acid\">glutamatergic</a> pathways, <font color=\"red\">red arrows</font> refer to inhibitory <a href=\"https://en.wikipedia.org/wiki/gamma-Aminobutyric_acid\" class=\"extiw\" title=\"en:gamma-Aminobutyric acid\">GABAergic</a> pathways and <font color=\"turquoise\">turquoise arrows</font> refer to <a href=\"https://en.wikipedia.org/wiki/dopamine\" class=\"extiw\" title=\"en:dopamine\">dopaminergic</a> pathways that are excitatory on the direct pathway and inhibitory on the indirect pathway. Note that dis-inhibitory pathways in effect are excitatory on the feedback to the cortex, while dis-dis-inhibitory pathways in effect are inhibitory. <i>See <a href=\"https://en.wikipedia.org/wiki/Basal_ganglia#Connections\" class=\"extiw\" title=\"en:Basal ganglia\">en:Basal ganglia#Connections</a></i>",
          "credit": "<p>Made in Inkscape. Source images:\n</p>\n<ul class=\"gallery mw-gallery-traditional\">\n\t\t<li class=\"gallerybox\" style=\"width: 155px\">\n\t\t\t<div class=\"thumb\" style=\"width: 150px; height: 150px;\"><span typeof=\"mw:File\"><a href=\"//commons.wikimedia.org/wiki/File:Brain_human_lateral_view.svg\" class=\"mw-file-description\" title=\"Brain human lateral view.svg (By Patrick J. Lynch; Creative Commons Attribution-Share Alike license)\"><img alt=\"Brain human lateral view.svg (By Patrick J. Lynch; Creative Commons Attribution-Share Alike license)\" src=\"https://upload.wikimedia.org/wikipedia/commons/thumb/4/44/Brain_human_lateral_view.svg/120px-Brain_human_lateral_view.svg.png\" decoding=\"async\" width=\"101\" height=\"120\" class=\"mw-file-element\" srcset=\"https://upload.wikimedia.org/wikipedia/commons/thumb/4/44/Brain_human_lateral_view.svg/250px-Brain_human_lateral_view.svg.png 1.5x\" data-file-width=\"295\" data-file-height=\"351\"></a></span></div>\n\t\t\t<div class=\"gallerytext\">Brain human lateral view.svg (By Patrick J. Lynch; Creative Commons Attribution-Share Alike license)</div>\n\t\t</li>\n\t\t<li class=\"gallerybox\" style=\"width: 155px\">\n\t\t\t<div class=\"thumb\" style=\"width: 150px; height: 150px;\"><span typeof=\"mw:File\"><a href=\"//commons.wikimedia.org/wiki/File:Basal_ganglia.svg\" class=\"mw-file-description\" title=\"Basal ganglia.svg (Based on work by Andrew Gillies/User:Anaru; Creative Commons Attribution ShareAlike + GFDL license)\"><img alt=\"Basal ganglia.svg (Based on work by Andrew Gillies/User:Anaru; Creative Commons Attribution ShareAlike + GFDL license)\" src=\"https://upload.wikimedia.org/wikipedia/commons/thumb/3/3e/Basal_ganglia.svg/120px-Basal_ganglia.svg.png\" decoding=\"async\" width=\"120\" height=\"53\" class=\"mw-file-element\" srcset=\"https://upload.wikimedia.org/wikipedia/commons/thumb/3/3e/Basal_ganglia.svg/250px-Basal_ganglia.svg.png 1.5x\" data-file-width=\"800\" data-file-height=\"350\"></a></span></div>\n\t\t\t<div class=\"gallerytext\">Basal ganglia.svg (Based on work by Andrew Gillies/User:Anaru; Creative Commons Attribution ShareAlike + GFDL license)</div>\n\t\t</li>\n</ul>\n<p>Sources for circuits: \n</p>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.biochem.arizona.edu/classes/bioc462/462bh2008/462bhonorsprojects/462bhonors2004/navratilovaz/IntroPD.htm\">Introduction to Parkinson's Disease</a> By Zaneta Navratilova. Last updated: May 10, 2004. Modified from Nestler et. al, 2001, p. 306 and Ottley et. al, 1999.</li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://emedicine.medscape.com/article/1151267-media\">eMedicine &gt; Parkinson Disease: Multimedia</a> Author: Robert A Hauser. Coauthor(s): Rajesh Pahwa, Kelly E Lyons, Theresa McClain. Updated: Apr 27, 2010</li></ul>",
          "license": "cc-by-sa-3.0",
          "url": "https://commons.wikimedia.org/wiki/File:Basal_ganglia_without_Parkinson's_disease.png"
        },
        {
          "title": "File:Paralysis agitans-Male Parkinson's victim-1892 cropped.png",
          "author": "Albert Londe (1858-1917)",
          "description": "Full length view of a male with Parkinson's disease, showing a walking posture.",
          "credit": "<a rel=\"nofollow\" class=\"external free\" href=\"http://ihm.nlm.nih.gov/luna/servlet/detail/NLMNLM~1~1~101435392~139330:-Paralysis-agitans---Male-Parkinson\">http://ihm.nlm.nih.gov/luna/servlet/detail/NLMNLM~1~1~101435392~139330:-Paralysis-agitans---Male-Parkinson</a>",
          "license": "pd",
          "url": "https://commons.wikimedia.org/wiki/File:Paralysis_agitans-Male_Parkinson's_victim-1892_cropped.png"
        },
        {
          "title": "File:Histological sample of Substantia nigra in Parkinson's disease cropped.jpg",
          "author": "Werner CJ., Heyny-von Haussen R., Mall G., Wolf S. Proteome analysis of human substantia nigra in Parkinson's disease.. Proteome Sci. 6, 8. 2008. doi:10.1186/1477-5956-6-8. <a class=\"external mw-magiclink-pmid\" rel=\"nofollow\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18275612?dopt=Abstract\">PMID 18275612</a>.",
          "description": "Histological sample of Substantia nigra in Parkinson's disease. Left: SNpc neuron with a Lewy body, extracellular neuromelanin and pigment-laden macrophages. Haematoxylin/Eosin stain, 500√ó. Right: Alpha-synuclein-positive Lewy neurit, 400√ó.\n<p>Retouched by <a class=\"external text\" href=\"https://en.wikipedia.org/wiki/User:Dustfreeworld\">User:Dustfreeworld</a>. Cropped. Sharpness, colour and brightness, etc. adjusted. Added a black arrow pointing to the Lewy body.\n</p><p>Source:\n<a href=\"//commons.wikimedia.org/wiki/File:Histological_sample_of_Substantia_nigra_in_Parkinson%27s_disease.jpg\" title=\"File:Histological sample of Substantia nigra in Parkinson's disease.jpg\">File:Histological_sample_of_Substantia_nigra_in_Parkinson's_disease.jpg</a>\n<a rel=\"nofollow\" class=\"external free\" href=\"https://www.ncbi.nlm.nih.gov/pubmed/18275612\">https://www.ncbi.nlm.nih.gov/pubmed/18275612</a>\n</p>\nWerner CJ., Heyny-von Haussen R., Mall G., Wolf S. Proteome analysis of human substantia nigra in Parkinson's disease.. Proteome Sci. 6, 8. 2008. doi:10.1186/1477-5956-6-8. <a class=\"external mw-magiclink-pmid\" rel=\"nofollow\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18275612?dopt=Abstract\">PMID 18275612</a>.",
          "credit": "<a href=\"//commons.wikimedia.org/wiki/File:Histological_sample_of_Substantia_nigra_in_Parkinson%27s_disease.jpg\" title=\"File:Histological sample of Substantia nigra in Parkinson's disease.jpg\">File:Histological_sample_of_Substantia_nigra_in_Parkinson's_disease.jpg</a>     <a rel=\"nofollow\" class=\"external free\" href=\"https://www.ncbi.nlm.nih.gov/pubmed/18275612/\">https://www.ncbi.nlm.nih.gov/pubmed/18275612/</a>",
          "license": "cc-by-2.0",
          "url": "https://commons.wikimedia.org/wiki/File:Histological_sample_of_Substantia_nigra_in_Parkinson's_disease_cropped.jpg"
        },
        {
          "title": "File:Person with Parkinson disease BW.jpg",
          "author": "William Gowers",
          "description": "Person with Parkinson‚Äôs disease. A retouched image from the drawings of a William Gowers. Color adjusted. Darker tone.",
          "credit": "<a class=\"external free\" href=\"https://commons.wikimedia.org/wiki/File:Drawings_of_a_Parkinson_patient_by_William_Gowers.jpg\">https://commons.wikimedia.org/wiki/File:Drawings_of_a_Parkinson_patient_by_William_Gowers.jpg</a>",
          "license": "pd",
          "url": "https://commons.wikimedia.org/wiki/File:Person_with_Parkinson_disease_BW.jpg"
        }
      ],
      [
        {
          "title": "File:Hypothetical model for the pathological interaction between Œ±-synuclein and nanoplastic contaminants in neurons.jpg",
          "author": "Authors of the study: Zhiyong Liu <a rel=\"nofollow\" class=\"external free\" href=\"https://orcid.org/0000-0002-2959-5189\">https://orcid.org/0000-0002-2959-5189</a>, Arpine Sokratian <a rel=\"nofollow\" class=\"external free\" href=\"https://orcid.org/0000-0001-6654-5773\">https://orcid.org/0000-0001-6654-5773</a>, Addison M. Duda <a rel=\"nofollow\" class=\"external free\" href=\"https://orcid.org/0000-0002-8116-4714\">https://orcid.org/0000-0002-8116-4714</a>, Enquan Xu, Christina Stanhope, Amber Fu <a rel=\"nofollow\" class=\"external free\" href=\"https://orcid.org/0009-0008-0898-9067\">https://orcid.org/0009-0008-0898-9067</a>, Samuel Strader <a rel=\"nofollow\" class=\"external free\" href=\"https://orcid.org/0000-0003-4417-3707\">https://orcid.org/0000-0003-4417-3707</a>, Huizhong Li <a rel=\"nofollow\" class=\"external free\" href=\"https://orcid.org/0009-0004-1228-0721\">https://orcid.org/0009-0004-1228-0721</a>, Yuan Yuan <a rel=\"nofollow\" class=\"external free\" href=\"https://orcid.org/0009-0002-3810-6487\">https://orcid.org/0009-0002-3810-6487</a>, Benjamin G. Bobay <a rel=\"nofollow\" class=\"external free\" href=\"https://orcid.org/0000-0003-4775-3686\">https://orcid.org/0000-0003-4775-3686</a>, Joana Sipe <a rel=\"nofollow\" class=\"external free\" href=\"https://orcid.org/0000-0001-5602-0922\">https://orcid.org/0000-0001-5602-0922</a>, Ketty Bai <a rel=\"nofollow\" class=\"external free\" href=\"https://orcid.org/0000-0002-9807-888X\">https://orcid.org/0000-0002-9807-888X</a>, Iben Lundgaard <a rel=\"nofollow\" class=\"external free\" href=\"https://orcid.org/0000-0001-9613-3892\">https://orcid.org/0000-0001-9613-3892</a>, Na Liu <a rel=\"nofollow\" class=\"external free\" href=\"https://orcid.org/0000-0002-3140-795X\">https://orcid.org/0000-0002-3140-795X</a>, Belinda Hernandez <a rel=\"nofollow\" class=\"external free\" href=\"https://orcid.org/0000-0001-5017-1447\">https://orcid.org/0000-0001-5017-1447</a>, Catherine Bowes Rickman, Sara E. Miller, and Andrew B. West <a rel=\"nofollow\" class=\"external free\" href=\"https://orcid.org/0000-0002-3034-4061\">https://orcid.org/0000-0002-3034-4061</a>",
          "description": "\"Nanoparticles that have the intrinsic capacity to disrupt and cross the blood-brain barrier, such as small charged polystyrene particles, may come into contact with neurons that express high levels of Œ±-synuclein and can harbor aggregates in disease. Peripheral cells susceptible to Œ±-synuclein aggregation and outside of the blood-brain barrier (e.g., vagal neurons) may also come into contact with nanoplastic contaminants. Both Œ±-synuclein fibrils and nanoplastics can enter the endolysosomal compartment in neurons through a clathrin-dependent endocytosis process. A healthy lysosome might fully degrade an Œ±-synuclein aggregate. However, if a lysosome is impaired by nanoplastic particles, Œ±-synuclein aggregates might not degrade and endogenous Œ±-synuclein trafficked to the lysosome may inadvertently spur the formation of new Œ±-synuclein fibrils through the potent pro-aggregation catalytic action of nanoplastics. This feedforward pathway highlights a two-part proposed mechanism whereby nanoplastic contaminants may accelerate the formation of misfolded Œ±-synuclein in the endolysosome compartment and simultaneously impair the degradative action of the organelles (i.e., lysosomes) primarily responsible for their clearance.\"",
          "credit": "<a rel=\"nofollow\" class=\"external free\" href=\"https://www.science.org/doi/10.1126/sciadv.adi8716\">https://www.science.org/doi/10.1126/sciadv.adi8716</a>",
          "license": "cc-by-4.0",
          "url": "https://commons.wikimedia.org/wiki/File:Hypothetical_model_for_the_pathological_interaction_between_Œ±-synuclein_and_nanoplastic_contaminants_in_neurons.jpg"
        },
        {
          "title": "File:Elevated-Œ±-synuclein-caused-by-SNCA-gene-triplication-impairs-neuronal-differentiation-and-cddis2015318x10.ogv",
          "author": "Oliveira L, Falomir-Lockhart L, Botelho M, Lin K, Wales P, Koch J, Gerhardt E, Taschenberger H, Outeiro T, Lingor P, Sch√ºle B, Arndt-Jovin D, Jovin T",
          "description": null,
          "credit": "<a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670926/bin/cddis2015318x10.mov\">Supplementary Movie 1</a> from <cite style=\"font-style:normal\">Oliveira L, Falomir-Lockhart L, Botelho M, Lin K, Wales P, Koch J, Gerhardt E, Taschenberger H, Outeiro T, Lingor P, Sch√ºle B, Arndt-Jovin D, Jovin T (2015). \"<a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670926\">Elevated Œ±-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson's patient-derived induced pluripotent stem cells</a>\". <i>Cell Death &amp; Disease</i>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/Digital_object_identifier\" class=\"extiw\" title=\"en:Digital object identifier\">DOI</a></span>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038/cddis.2015.318\">10.1038/cddis.2015.318</a>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/PubMed\" class=\"extiw\" title=\"en:PubMed\"><span lang=\"en\" dir=\"ltr\">PMID</span></a></span> <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pubmed/26610207\">26610207</a>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/PubMed_Central\" class=\"extiw\" title=\"en:PubMed Central\"><span lang=\"en\" dir=\"ltr\">PMC</span></a></span>: <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670926\">4670926</a>.</cite>",
          "license": "cc-by-4.0",
          "url": "https://commons.wikimedia.org/wiki/File:Elevated-Œ±-synuclein-caused-by-SNCA-gene-triplication-impairs-neuronal-differentiation-and-cddis2015318x10.ogv"
        },
        {
          "title": "File:Membrane-Permeabilization-by-Oligomeric-Œ±-Synuclein-In-Search-of-the-Mechanism-pone.0014292.s001.ogv",
          "author": "van Rooijen B, Claessens M, Subramaniam V",
          "description": "Confocal microscopy movie of POPG GUVs filled with the dye HPTS (green) in a flow chamber. The quencher DPX was present on the outside of the vesicles. The GUV membrane was stained with DOPE-Rhodamine (red). An aliquot of oligomers was introduced into the chamber (top of the image frames), and imaging was continued.",
          "credit": "Movie S1 from <cite style=\"font-style:normal\">van Rooijen B, Claessens M, Subramaniam V (2010). \"<a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001441\">Membrane Permeabilization by Oligomeric Œ±-Synuclein: In Search of the Mechanism</a>\". <i>PLOS ONE</i>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/Digital_object_identifier\" class=\"extiw\" title=\"en:Digital object identifier\">DOI</a></span>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1371/journal.pone.0014292\">10.1371/journal.pone.0014292</a>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/PubMed\" class=\"extiw\" title=\"en:PubMed\"><span lang=\"en\" dir=\"ltr\">PMID</span></a></span> <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pubmed/21179192\">21179192</a>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/PubMed_Central\" class=\"extiw\" title=\"en:PubMed Central\"><span lang=\"en\" dir=\"ltr\">PMC</span></a></span>: <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001441\">3001441</a>.</cite>",
          "license": "cc-by-2.5",
          "url": "https://commons.wikimedia.org/wiki/File:Membrane-Permeabilization-by-Oligomeric-Œ±-Synuclein-In-Search-of-the-Mechanism-pone.0014292.s001.ogv"
        },
        {
          "title": "File:Astrocytic-expression-of-Parkinson's-disease-related-A53T-Œ±-synuclein-causes-neurodegeneration-in-1756-6606-3-12-S4.ogv",
          "author": "Gu X, Long C, Sun L, Xie C, Lin X, Cai H",
          "description": "Symptomatic A53T mice were only able to run at the speed of 5 cm/s. The first mouse showed paralysis in both forelimbs. The second mouse displayed paralysis in the left forelimb and in both hindlimbs.",
          "credit": "<cite style=\"font-style:normal\">Gu X, Long C, Sun L, Xie C, Lin X, Cai H (2010). \"<a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873589\">Astrocytic expression of Parkinson's disease-related A53T Œ±-synuclein causes neurodegeneration in mice</a>\". <i>Molecular Brain</i>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/Digital_object_identifier\" class=\"extiw\" title=\"en:Digital object identifier\">DOI</a></span>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1186/1756-6606-3-12\">10.1186/1756-6606-3-12</a>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/PubMed\" class=\"extiw\" title=\"en:PubMed\"><span lang=\"en\" dir=\"ltr\">PMID</span></a></span> <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pubmed/20409326\">20409326</a>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/PubMed_Central\" class=\"extiw\" title=\"en:PubMed Central\"><span lang=\"en\" dir=\"ltr\">PMC</span></a></span>: <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873589\">2873589</a>.</cite>",
          "license": "cc-by-2.0",
          "url": "https://commons.wikimedia.org/wiki/File:Astrocytic-expression-of-Parkinson's-disease-related-A53T-Œ±-synuclein-causes-neurodegeneration-in-1756-6606-3-12-S4.ogv"
        },
        {
          "title": "File:Œë-synuclein-transfer-through-tunneling-nanotubes-occurs-in-SH-SY5Y-cells-and-primary-brain-srep42984-s2.ogv",
          "author": "Dieriks B, Park T, Fourie C, Faull R, Dragunow M, Curtis M",
          "description": "Supplementary Movie 1",
          "credit": "<a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322400/bin/srep42984-s2.mov\">Video file</a> from <cite style=\"font-style:normal\">Dieriks B, Park T, Fourie C, Faull R, Dragunow M, Curtis M (2017). \"<a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322400\">Œ±-synuclein transfer through tunneling nanotubes occurs in SH-SY5Y cells and primary brain pericytes from Parkinson‚Äôs disease patients</a>\". <i>Scientific Reports</i>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/Digital_object_identifier\" class=\"extiw\" title=\"en:Digital object identifier\">DOI</a></span>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038/srep42984\">10.1038/srep42984</a>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/PubMed\" class=\"extiw\" title=\"en:PubMed\"><span lang=\"en\" dir=\"ltr\">PMID</span></a></span> <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pubmed/28230073\">28230073</a>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/PubMed_Central\" class=\"extiw\" title=\"en:PubMed Central\"><span lang=\"en\" dir=\"ltr\">PMC</span></a></span>: <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322400\">5322400</a>.</cite>",
          "license": "cc-by-4.0",
          "url": "https://commons.wikimedia.org/wiki/File:Œë-synuclein-transfer-through-tunneling-nanotubes-occurs-in-SH-SY5Y-cells-and-primary-brain-srep42984-s2.ogv"
        },
        {
          "title": "File:Astrocytic-expression-of-Parkinson's-disease-related-A53T-Œ±-synuclein-causes-neurodegeneration-in-1756-6606-3-12-S5.ogv",
          "author": "Gu X, Long C, Sun L, Xie C, Lin X, Cai H",
          "description": "A53T mice developed rapid progression of paralysis in four limbs. This mouse was able to run at the speed of 5 cm/s on postnatal day 65 (P65), but 2 cm/s on P70. The right forelimb started to show paralysis on P71 and then the left forelimb was affected on P73.",
          "credit": "<cite style=\"font-style:normal\">Gu X, Long C, Sun L, Xie C, Lin X, Cai H (2010). \"<a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873589\">Astrocytic expression of Parkinson's disease-related A53T Œ±-synuclein causes neurodegeneration in mice</a>\". <i>Molecular Brain</i>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/Digital_object_identifier\" class=\"extiw\" title=\"en:Digital object identifier\">DOI</a></span>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1186/1756-6606-3-12\">10.1186/1756-6606-3-12</a>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/PubMed\" class=\"extiw\" title=\"en:PubMed\"><span lang=\"en\" dir=\"ltr\">PMID</span></a></span> <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pubmed/20409326\">20409326</a>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/PubMed_Central\" class=\"extiw\" title=\"en:PubMed Central\"><span lang=\"en\" dir=\"ltr\">PMC</span></a></span>: <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873589\">2873589</a>.</cite>",
          "license": "cc-by-2.0",
          "url": "https://commons.wikimedia.org/wiki/File:Astrocytic-expression-of-Parkinson's-disease-related-A53T-Œ±-synuclein-causes-neurodegeneration-in-1756-6606-3-12-S5.ogv"
        },
        {
          "title": "File:Œë-synuclein-transfer-through-tunneling-nanotubes-occurs-in-SH-SY5Y-cells-and-primary-brain-srep42984-s3.ogv",
          "author": "Dieriks B, Park T, Fourie C, Faull R, Dragunow M, Curtis M",
          "description": "Supplementary Movie 2",
          "credit": "<a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322400/bin/srep42984-s3.mov\">Video file</a> from <cite style=\"font-style:normal\">Dieriks B, Park T, Fourie C, Faull R, Dragunow M, Curtis M (2017). \"<a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322400\">Œ±-synuclein transfer through tunneling nanotubes occurs in SH-SY5Y cells and primary brain pericytes from Parkinson‚Äôs disease patients</a>\". <i>Scientific Reports</i>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/Digital_object_identifier\" class=\"extiw\" title=\"en:Digital object identifier\">DOI</a></span>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038/srep42984\">10.1038/srep42984</a>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/PubMed\" class=\"extiw\" title=\"en:PubMed\"><span lang=\"en\" dir=\"ltr\">PMID</span></a></span> <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pubmed/28230073\">28230073</a>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/PubMed_Central\" class=\"extiw\" title=\"en:PubMed Central\"><span lang=\"en\" dir=\"ltr\">PMC</span></a></span>: <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322400\">5322400</a>.</cite>",
          "license": "cc-by-4.0",
          "url": "https://commons.wikimedia.org/wiki/File:Œë-synuclein-transfer-through-tunneling-nanotubes-occurs-in-SH-SY5Y-cells-and-primary-brain-srep42984-s3.ogv"
        },
        {
          "title": "File:Astrocytic-expression-of-Parkinson's-disease-related-A53T-Œ±-synuclein-causes-neurodegeneration-in-1756-6606-3-12-S3.ogv",
          "author": "Gu X, Long C, Sun L, Xie C, Lin X, Cai H",
          "description": "The TreadScan Gait Analysis System (Clever Sys, Reston, VA) was used to record the gait information of A53T mice. Each mouse was placed on the belt of treadmill unit. The movement of each paw was recorded with the treadmill running at 17 cm/s, 5 cm/s and 2 cm/s, respectively [54]. A representative control nTg mouse was running on the treadmill with the speed set at 17 cm/s. The later part of movie was replayed four times slower than the first part to better visualize the placement of each paw on the belt.",
          "credit": "<cite style=\"font-style:normal\">Gu X, Long C, Sun L, Xie C, Lin X, Cai H (2010). \"<a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873589\">Astrocytic expression of Parkinson's disease-related A53T Œ±-synuclein causes neurodegeneration in mice</a>\". <i>Molecular Brain</i>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/Digital_object_identifier\" class=\"extiw\" title=\"en:Digital object identifier\">DOI</a></span>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1186/1756-6606-3-12\">10.1186/1756-6606-3-12</a>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/PubMed\" class=\"extiw\" title=\"en:PubMed\"><span lang=\"en\" dir=\"ltr\">PMID</span></a></span> <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pubmed/20409326\">20409326</a>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/PubMed_Central\" class=\"extiw\" title=\"en:PubMed Central\"><span lang=\"en\" dir=\"ltr\">PMC</span></a></span>: <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873589\">2873589</a>.</cite>",
          "license": "cc-by-2.0",
          "url": "https://commons.wikimedia.org/wiki/File:Astrocytic-expression-of-Parkinson's-disease-related-A53T-Œ±-synuclein-causes-neurodegeneration-in-1756-6606-3-12-S3.ogv"
        },
        {
          "title": "File:Events in alpha synuclein toxicity.jpg",
          "author": "Mark R Cookson",
          "description": "Events in Œ±-synuclein toxicity. The central panel shows the major pathway for protein aggregation. Monomeric Œ±-synuclein is natively unfolded in solution but can also bind to membranes in an Œ±-helical form. It seems likely that these two species exist in equilibrium within the cell, although this is unproven. From in vitro work, it is clear that unfolded monomer can aggregate first into small oligomeric species that can be stabilized by Œ≤-sheet-like interactions and then into higher molecular weight insoluble fibrils. In a cellular context, there is some evidence that the presence of lipids can promote oligomer formation: Œ±-synuclein can also form annular, pore-like structures that interact with membranes. The deposition of Œ±-synuclein into pathological structures such as Lewy bodies is probably a late event that occurs in some neurons. On the left hand side are some of the known modifiers of this process. Electrical activity in neurons changes the association of Œ±-synuclein with vesicles and may also stimulate polo-like kinase 2 (PLK2), which has been shown to phosphorylate Œ±-synuclein at Ser129. Other kinases have also been proposed to be involved. As well as phosphorylation, truncation through proteases such as calpains, and nitration, probably through nitric oxide (NO) or other reactive nitrogen species that are present during inflammation, all modify synuclein such that it has a higher tendency to aggregate. The addition of ubiquitin (shown as a black spot) to Lewy bodies is probably a secondary process to deposition. On the right are some of the proposed cellular targets for Œ±-synuclein mediated toxicity, which include (from top to bottom) ER-golgi transport, synaptic vesicles, mitochondria and lysosomes and other proteolytic machinery. In each of these cases, it is proposed that Œ±-synuclein has detrimental effects, listed below each arrow, although at this time it is not clear if any of these are either necessary or sufficient for toxicity in neurons. Cookson Molecular Neurodegeneration 2009 4:9   <a href=\"//doi.org/10.1186/1750-1326-4-9\" class=\"extiw\" title=\"doi:10.1186/1750-1326-4-9\">doi:10.1186/1750-1326-4-9</a>",
          "credit": "<a rel=\"nofollow\" class=\"external text\" href=\"http://www.molecularneurodegeneration.com/content/4/1/9\">Œ±-Synuclein and neuronal cell death</a>",
          "license": "cc-by-2.0",
          "url": "https://commons.wikimedia.org/wiki/File:Events_in_alpha_synuclein_toxicity.jpg"
        }
      ],
      [
        {
          "title": "File:SESI and biomarker discovery.png",
          "author": "<a href=\"//commons.wikimedia.org/w/index.php?title=User:Paola.navarro.fit&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"User:Paola.navarro.fit (page does not exist)\">Paola.navarro.fit</a>",
          "description": "High throughput biomarker discovery using SESI",
          "credit": "<span class=\"int-own-work\" lang=\"en\">Own work</span>",
          "license": "cc-by-sa-4.0",
          "url": "https://commons.wikimedia.org/wiki/File:SESI_and_biomarker_discovery.png"
        },
        {
          "title": "File:Biomarker Publications in Scholia.png",
          "author": "<a href=\"//commons.wikimedia.org/wiki/User:Prototyperspective\" class=\"mw-redirect\" title=\"User:Prototyperspective\">Prototyperspective</a>",
          "description": "Screenshot of <a class=\"external free\" href=\"https://scholia.toolforge.org/chemical-class/Q864574#publications-per-year\">https://scholia.toolforge.org/chemical-class/Q864574#publications-per-year</a>\nThere are also databases about biomarkers and the number of biomarker-related publications may not follow closely the number of viable biomarkers.",
          "credit": "<span class=\"int-own-work\" lang=\"en\">Own work</span>",
          "license": "cc-by-4.0",
          "url": "https://commons.wikimedia.org/wiki/File:Biomarker_Publications_in_Scholia.png"
        }
      ]
    ]
  },
  {
    "title": "Promising results for antisense RNA therapy in mouse models of diffuse midline glioma",
    "authors": [
      "Barranco, Caroline"
    ],
    "abstract": [
      ""
    ],
    "url": "https://doi.org/10.1038/s41582-023-00829-8",
    "journal": "Nature Reviews Neurology",
    "keywords": [
      "antisense RNA therapy",
      "diffuse midline glioma",
      "CRISPR-Cas9"
    ],
    "caption": "üß¨ Exciting breakthroughs in neuroscience! A new study shows promising results for antisense RNA therapy targeting the H3.3K27M variant in diffuse midline glioma, a highly aggressive brain cancer mainly affecting children. Using CRISPR-Cas9 technology in mice, researchers successfully delayed tumor growth and extended survival. This innovative approach offers hope for more effective treatments beyond current options like histone deacetylase inhibitors. While still in early stages, these findings could pave the way for life-saving therapies in pediatric oncology. üåü #Neuroscience #CancerResearch #Glioma #RNAtherapy #CRISPR #PediatricCancer #HopeInScience",
    "images": [
      [
        {
          "title": "File:Antisense Oligonucleotide Use in ncRNA therapy.png",
          "author": "<a href=\"//commons.wikimedia.org/w/index.php?title=User:KB-OKO&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"User:KB-OKO (page does not exist)\">KB-OKO</a>",
          "description": "ASO (Antisense oligonucleotide) are indicated as blue single stranded molecules in the cytoplasm. Double stranded siRNAs are indicated as a blue and red strand incorporated together. 1. Once they enter the nucleus, they undergo further modifications allowing them to bind to their target (lncRNA or mRNA) and degrade them using RNase H.The degradation of mRNA and lncRNA can be done through the use of siRNA in conjunction with RISC complexes found inside the cytoplasm or nucleus. ASOs can also be used to preferentially modulate processing of mRNA and lncRNA transcripts. The ASO has the ability to bind to pre-mRNA structure and directly modulate splicing (5), by masking splicing enhancer and repressors sequences, causing skipping in exons (2). It also has the ability to modulate polyadenylation selection in those transcripts with more than one polyA site in the 3'-UTR (6). We can also have the ASO binding to mRNA and sterically blocking the ribosomal subunits from translation into proteins (3), this can also be done using siRNA. In order to target ncRNAs within the nucleus we can also make use of viruses, which can be used to knockout (short RNA) shRNA or lncRNA (4), same vectors can also be used to upregulate lncRNA activity.",
          "credit": "<span class=\"int-own-work\" lang=\"en\">Own work</span>",
          "license": "cc-by-sa-4.0",
          "url": "https://commons.wikimedia.org/wiki/File:Antisense_Oligonucleotide_Use_in_ncRNA_therapy.png"
        }
      ],
      [
        {
          "title": "File:Diffuse midline glioma MRI.jpg",
          "author": "Huang T., Garcia R., Qi J., Lulla R., Horbinski C., Behdad A., Wadhwani N., Shilatifard A., James C., Saratsis A. M.",
          "description": "Magnetic resonance imaging characteristics (MRI) of pediatric diffuse midline glioma. Pediatric diffuse midline glioma arise in the brainstem (A, B) or thalamus (C, D). T2 weighted MR imaging (A, B, C) demonstrates a homogenous, expansile, infiltrative lesion with extension within white matter tracts. Minimal to heterogenous enhancement may be observed on T1 post-gadolinium sequences (D). Local mass effect and perilesional edema may also be seen.",
          "credit": "<a rel=\"nofollow\" class=\"external free\" href=\"https://doi.org/10.18632/oncotarget.26430\">https://doi.org/10.18632/oncotarget.26430</a>",
          "license": "cc-by-4.0",
          "url": "https://commons.wikimedia.org/wiki/File:Diffuse_midline_glioma_MRI.jpg"
        },
        {
          "title": "File:Pediatric diffuse intrinsic pontine glioma.jpg",
          "author": "Benjamin T. Himes, Liang Zhang, David J. Daniels",
          "description": "MRI imaging of an 8 year-old girl with a diffuse intrinsic pontine glioma (DIPG) tumor (white arrows). T2-weighted sagittal (A) and axial (B) images demonstrate the enlargement of the brainstem and highlight the diffuse infiltrative characteristic of DIPG tumors. (C,D) Gadolinium-enhanced T1-weighted MRI images of the same patient demonstrating scant patchy enhancement.",
          "credit": "<a rel=\"nofollow\" class=\"external free\" href=\"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2019.00031/full\">https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2019.00031/full</a>",
          "license": "cc-by-4.0",
          "url": "https://commons.wikimedia.org/wiki/File:Pediatric_diffuse_intrinsic_pontine_glioma.jpg"
        },
        {
          "title": "File:Diffuse midline glioma MRI (cropped).jpg",
          "author": "Huang T., Garcia R., Qi J., Lulla R., Horbinski C., Behdad A., Wadhwani N., Shilatifard A., James C., Saratsis A. M.",
          "description": "Magnetic resonance imaging characteristics (MRI) of pediatric diffuse midline glioma. Pediatric diffuse midline glioma arise in the brainstem (A, B) or thalamus (C, D). T2 weighted MR imaging (A, B, C) demonstrates a homogenous, expansile, infiltrative lesion with extension within white matter tracts. Minimal to heterogenous enhancement may be observed on T1 post-gadolinium sequences (D). Local mass effect and perilesional edema may also be seen.",
          "credit": "<a rel=\"nofollow\" class=\"external free\" href=\"https://doi.org/10.18632/oncotarget.26430\">https://doi.org/10.18632/oncotarget.26430</a>",
          "license": "cc-by-4.0",
          "url": "https://commons.wikimedia.org/wiki/File:Diffuse_midline_glioma_MRI_(cropped).jpg"
        },
        {
          "title": "File:Diffuse midline glioma MRI (A+B).jpg",
          "author": "Huang T., Garcia R., Qi J., Lulla R., Horbinski C., Behdad A., Wadhwani N., Shilatifard A., James C., Saratsis A. M.",
          "description": "Magnetic resonance imaging characteristics (MRI) of pediatric diffuse midline glioma. Pediatric diffuse midline glioma arise in the brainstem (A, B) or thalamus (C, D). T2 weighted MR imaging (A, B, C) demonstrates a homogenous, expansile, infiltrative lesion with extension within white matter tracts. Minimal to heterogenous enhancement may be observed on T1 post-gadolinium sequences (D). Local mass effect and perilesional edema may also be seen.",
          "credit": "<a rel=\"nofollow\" class=\"external free\" href=\"https://doi.org/10.18632/oncotarget.26430\">https://doi.org/10.18632/oncotarget.26430</a>",
          "license": "cc-by-4.0",
          "url": "https://commons.wikimedia.org/wiki/File:Diffuse_midline_glioma_MRI_(A+B).jpg"
        },
        {
          "title": "File:Diagnosis of diffuse glioma.png",
          "author": "Weller M, van den Bent M, Preusser M, Le Rhun E, Tonn JC, Minniti G et al<br>Few colored boxes added by <a href=\"//commons.wikimedia.org/wiki/User:Mikael_H%C3%A4ggstr%C3%B6m\" title=\"User:Mikael H√§ggstr√∂m\">Mikael H√§ggstr√∂m</a>",
          "description": "Diagnostic algorithm for the integrated classification of the major diffuse gliomas in adults. Tissue specimens obtained through biopsy sampling in patients with diffuse gliomas are routinely assessed by immunohistochemistry for the presence of R132H-mutant IDH1 and loss of nuclear ATRX. In patients aged &gt;55 years with a histologically typical glioblastoma, without a pre-existing lower grade glioma, with a non-midline tumor location and with retained nuclear ATRX expression, immunohistochemical negativity for IDH1 R132H suffices for the classification as IDH-wild-type glioblastoma. In all other instances of diffuse gliomas, a lack of IDH1 R132H immunopositivity should be followed by IDH1 and IDH2 DNA sequencing to detect or exclude the presence of non-canonical mutations. IDH-wild-type diffuse astrocytic gliomas without microvascular proliferation or necrosis should be tested for EGFR amplification, TERT promoter mutation and a +7/‚Äì10 cytogenetic signature as molecular characteristics of IDH-wild-type glioblastomas. In addition, the presence of histone H3.3 G34R/V mutations should be assessed by immunohistochemistry or DNA sequencing to identify H3.3 G34-mutant diffuse hemispheric gliomas, in particular in young patients with IDH-wild-type gliomas (such as those &lt;50 years of age with nuclear ATRX loss in tumour cells). Diffuse gliomas of the thalamus, brainstem or spinal cord should be evaluated for histone H3 K27M mutations and loss of nuclear K27-trimethylated histone H3 (H3K27me3) to identify H3 K27M-mutant diffuse midline gliomas. The presence and absence of the diagnostically most relevant molecular alterations for each tumor type are highlighted with red and green boxes. MVP, microvascular proliferation.",
          "credit": "<cite style=\"font-style:normal\">Weller M, van den Bent M, Preusser M, Le Rhun E, Tonn JC, Minniti G (2021). \"<a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904519\">EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood.</a>\". <i>Nat Rev Clin Oncol</i> <b>18</b> (3): 170-186. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/Digital_object_identifier\" class=\"extiw\" title=\"en:Digital object identifier\">DOI</a></span>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1038/s41571-020-00447-z\">10.1038/s41571-020-00447-z</a>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/PubMed\" class=\"extiw\" title=\"en:PubMed\"><span lang=\"en\" dir=\"ltr\">PMID</span></a></span> <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pubmed/33293629\">33293629</a>. <span lang=\"en\" dir=\"ltr\"><a href=\"https://en.wikipedia.org/wiki/PubMed_Central\" class=\"extiw\" title=\"en:PubMed Central\"><span lang=\"en\" dir=\"ltr\">PMC</span></a></span>: <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904519\">7904519</a>.</cite><br>\"This article is licensed under a Creative Commons Attribution 4.0 International License\"",
          "license": "cc-by-sa-4.0",
          "url": "https://commons.wikimedia.org/wiki/File:Diagnosis_of_diffuse_glioma.png"
        },
        {
          "title": "File:K27M mutant diffuse glioma of the midline.jpg",
          "author": "<a href=\"//commons.wikimedia.org/w/index.php?title=User:Jensflorian&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"User:Jensflorian (page does not exist)\">Jensflorian</a>",
          "description": "Pathology specimen with nuclear H3F3A K27M immunostaining (brown) in a diffuse glioma of the midline.",
          "credit": "<span class=\"int-own-work\" lang=\"en\">Own work</span>",
          "license": "cc-by-sa-4.0",
          "url": "https://commons.wikimedia.org/wiki/File:K27M_mutant_diffuse_glioma_of_the_midline.jpg"
        }
      ],
      [
        {
          "title": "File:CRISPR Cas9.png",
          "author": "Anna Drangowska-Way, Caitlin M. A. Simopoulos, Carla Bautista, Elisabeth Marnik, Thomas J. S. Merritt",
          "description": "A prote√≠na Cas9 √© levada pelo RNA guia ao local certo no gene. B. O local PAM mostra √† Cas9 onde ela deve cortar o DNA. C. O modelo de reparo, contendo a mudan√ßa que queremos fazer no gene, encontra a √°rea cortada e ajuda a fixar o DNA. D. O DNA reparado inclui as mudan√ßas desejadas.",
          "credit": "<a rel=\"nofollow\" class=\"external free\" href=\"https://parajovens.unesp.br/crispr-uma-nova-maneira-para-editar-o-dna/\">https://parajovens.unesp.br/crispr-uma-nova-maneira-para-editar-o-dna/</a>",
          "license": "cc-by-4.0",
          "url": "https://commons.wikimedia.org/wiki/File:CRISPR_Cas9.png"
        },
        {
          "title": "File:Sistema CRISPR-Cas9.png",
          "author": "Laura Parra Villar- Reproducci√≥n Asistida ORG",
          "description": "Este sistema se basa en la replicaci√≥n y conservaci√≥n de fragmentos de ADN v√≠rico dentro del ADN de la bacteria que ha sido infectada.",
          "credit": "<a rel=\"nofollow\" class=\"external free\" href=\"https://www.reproduccionasistida.org/autorizacion-de-modificacion-de-embriones/sistema-crispr-cas9/\">https://www.reproduccionasistida.org/autorizacion-de-modificacion-de-embriones/sistema-crispr-cas9/</a>",
          "license": "cc-by-sa-4.0",
          "url": "https://commons.wikimedia.org/wiki/File:Sistema_CRISPR-Cas9.png"
        },
        {
          "title": "File:Genome-wide CRISPR-Cas9 Knockout Screens.png",
          "author": "<a href=\"//commons.wikimedia.org/w/index.php?title=User:Sdpg123&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"User:Sdpg123 (page does not exist)\">Sdpg123</a>",
          "description": "General workflow Genome-wide CRSIPR-Cas9 Knockout Screens. The first step, sgRNA library creation, can be skipped by obtaining a commercially available library. Created with BioRender.com.",
          "credit": "<span class=\"int-own-work\" lang=\"en\">Own work</span>",
          "license": "cc-by-sa-4.0",
          "url": "https://commons.wikimedia.org/wiki/File:Genome-wide_CRISPR-Cas9_Knockout_Screens.png"
        },
        {
          "title": "File:CRISPR-Cas9 gene editing and how it works - with Jennifer Doudna.webm",
          "author": "Roxanne Makasdjian and Stephen McNally for the <a rel=\"nofollow\" class=\"external text\" href=\"https://www.youtube.com/channel/UCZAXKyvvIV4uU4YvP5dmrmA\">University of California, Berkeley</a>",
          "description": "What is CRISPR-Cas9 and how does it work?  How do we edit genes?  Jennifer Doudna, biochemist at UC Berkeley, explains.\n<p>The gene editing technique, created by UC Berkeley biochemist Jennifer Doudna and her colleague, Emmanuelle Charpentier, director of the Max Planck Institute of Infection Biology in Berlin, has taken the research and clinical communities by storm as an easy and cheap way to make precise changes in DNA in order to disable genes, correct genetic disorders or insert mutated genes into animals to create models of human disease.\n</p>\nCRISPR-Cas9 is a hybrid of protein and RNA ‚Äì the cousin to DNA ‚Äì that functions as an efficient search-and-snip system in bacteria. It arose as a way to recognize and kill viruses, but Doudna and Charpentier realized that it could also work well in other cells, including humans, to facilitate genome editing. The Cas9 protein, obtained from the bacteria Streptococcus pyogenes, functions together with a ‚Äúguide‚Äù RNA that targets a complementary 20-nucleotide stretch of DNA. Once the RNA identifies a sequence matching these nucleotides, Cas9 cuts the double-stranded DNA helix.",
          "credit": "<bdi lang=\"en\" dir=\"ltr\"><a href=\"//commons.wikimedia.org/wiki/Commons:YouTube_files\" title=\"Commons:YouTube files\">YouTube</a>: <a rel=\"nofollow\" class=\"external text\" href=\"https://www.youtube.com/watch?v=avM1Yg5oEu0\"><bdi lang=\"\">CRISPR-Cas9 gene editing and how it works - with Jennifer Doudna</bdi></a></bdi>",
          "license": "cc-by-3.0",
          "url": "https://commons.wikimedia.org/wiki/File:CRISPR-Cas9_gene_editing_and_how_it_works_-_with_Jennifer_Doudna.webm"
        }
      ]
    ]
  }
]